Introduction {#Sec1}
============

Mothers' milk is a source of nutrients, energy, and protection for the newborn child, and it carries essential elements from the mother to the child (Kramer and Kakuma [@CR137]). Due to the lipophilic properties of a range of anthropogenic organic pollutants, ubiquitously distributed in human food and our environment, many of these chemicals are accumulated in mothers' milk. Accordingly, the nursing child is targeted by a vast number of undesirable pollutants (IPCS [@CR119]; UNEP and WHO [@CR264]). These pollutants are similar to those entering the fetus via the cord blood after transfer across the placental barrier (CDC [@CR39]; Frederiksen et al. [@CR89]), although there are differences in the presence of pollutants in the blood and in the mothers' milk. Due to the high chemical and metabolic stability and toxicity of some anthropogenic chemicals as well as their ability to spread globally, and bioaccumulate, 25 chemicals have been adopted under the Stockholm Convention (SCa), known as persistent organic pollutants (POPs). Among these listed POPs, polybrominated diphenyl ethers (PBDEs) are separated into tetra-/pentaBDEs and hexa-/heptaBDEs, which actually make the POPs to 24 different entries. Six other POPs are presently under discussion for inclusion among the legacy POPs (SCb), and among these, short chain chlorinated paraffins (SCCPs) are included in the present review. The POPs reviewed herein are listed in Table [1](#Tab1){ref-type="table"}.Table 1Names and abbreviations of all POPs and two suggested POPs are presented, CAS numbers are given, as well as chemical structures or general structures. Some major review documents regarding the POPs are presented under "Review articles" (the column to the far right)

The overarching toxicity of POPs is related to endocrine disruption (UNEP and WHO [@CR264]) and/or listed as carcinogenic, mutagenic, or reprotoxic (CMRs). The toxicities of the POPs are extensively studied and will not be discussed in any detail here; instead, we prefer to refer to some of the most recent reviews on the different POPs listed in Table [1](#Tab1){ref-type="table"}. Toxicological data for many of the POPs are often related to accidental exposures to humans or wildlife and considerable animal testing in toxicological laboratories. Some of the POPs show acute toxicity, like the "drins" (i.e., dieldrin, endrin, and aldrin). On the contrary, chronic effects have been observed for, e.g., DDT, and its transformation product dichlorodiphenyldichloroethylene (DDE), effects which were particularly emphasized in birds. The effects of many of the POPs on reproduction have been shown among wildlife species.

Accordingly, it is of interest to review the present exposure situation to POPs for nursing children worldwide, i.e., spatial exposure data as well as levels of POPs in mothers' milk over time. The objective of this review is to summarize the concentrations of POPs in mothers' milk during a delimited time period, 1995--2011. In addition, some recent data have been generated within the Swedish monitoring program and are included herein.

Analysis of some of the first identified POPs in mothers' milk was published in the 1960s (Norén and Westöö [@CR179]) and then novel POPs were added to the list (Westöö and Norén [@CR280]). Still, as shown herein, there is limited mothers' milk data for several of the POPs.

Materials and methods {#Sec2}
=====================

Names, abbreviations, and (general) structures of the POPs applied in the present review are presented in Table [1](#Tab1){ref-type="table"}, together with reviews discussing their toxicities/ecotoxicological effects.

Methods for data retrieval on POPs in mothers' milk {#Sec3}
---------------------------------------------------

A literature search was performed using the database Web of Science and the following search terms were used: "Human Milk," "Breast Milk," "Mother's Milk," and "Mothers Milk," combined with the name of the substance of interest. All references found were compiled in one database and duplicates were removed.

Methods for inclusion of data {#Sec4}
-----------------------------

To reduce errors due to comparison of data from different sources and to avoid presenting a historical overview, the following limits were set for inclusion in the study:The study must be a scientific peer-reviewed paper published 1995--2011.Studies must report and quantify any of the POPs listed in Table [1](#Tab1){ref-type="table"}, in at least six subjects (donors). In the case of pooled samples, a pool should contain a minimum of six donors.Information about place and year of sampling are required.Inclusion of a time series requires a minimum of five reported data points and is only included if the report/paper includes the original values of the time series.

Other sources of data {#Sec5}
---------------------

Data from the Swedish Environmental Monitoring Program are included herein ([http://www.imm.ki.se/Datavard/aBiologiska_mätdata\_-\_organiska_ämnen](http://www.imm.ki.se/Datavard/aBiologiska_m%C3%A4tdata_-_organiska_%C3%A4mnen)), as well as time series data from Fång et al. ([@CR84]).

Substance summary tables {#Sec6}
------------------------

Concentration data are presented in the substance summary tables (Tables [2](#Tab2){ref-type="table"}, [3](#Tab3){ref-type="table"}, [4](#Tab4){ref-type="table"}, [5](#Tab5){ref-type="table"}, [6](#Tab6){ref-type="table"}, [7](#Tab7){ref-type="table"}, [8](#Tab8){ref-type="table"}, [9](#Tab9){ref-type="table"}, [10](#Tab10){ref-type="table"}, [11](#Tab11){ref-type="table"}, [12](#Tab12){ref-type="table"}, and [13](#Tab13){ref-type="table"}) in the following manner:Table 2Concentrations (ng/g fat) of 4,4′-DDT and its metabolites/transformation products, 4,4′-DDE, 4,4′-DDD, and ∑DDT, in mothers' milk, as reported in studies from around the world, 1995--2011. The concentration ratio of 4,4′-DDT/4,4′-DDE has been calculated and is presented in the tableRegionCountry4,4′-DDE4,4′-DDD4,4′-DDT∑DDTs4,4′-DDT/4,4′-DDEReferenceMeanMedianGMMeanMedianGMMeanMedianGMMeanMedianGMMeanMedianGMAfricaAfrica980UNEP ([@CR263])Cambodia1200; 1800860; 1100Kunisue et al. ([@CR142])Egypt530^a^73.25^a^0.14Saleh et al. ([@CR209])Ghana45831780.70Ntow et al. ([@CR182])Ghana490Ntow ([@CR181])Ghana230UNEP ([@CR262])Libya120120420Elafi et al. ([@CR77])Mozambique3301907.53.8220675502800.670.35Manaca et al. ([@CR160])Nigeria860UNEP ([@CR262])Senegal460UNEP ([@CR262])South Africa490--300036--91260--1700800--48000.53--0.66Bouwman et al. ([@CR32])South Africa460036001600890630049000.350.25Darnerud et al. ([@CR65])South Africa70,000^a^44,000^a^40,000^a^150,000^a^0.57Okonkwo et al. ([@CR185])South Africa2700; 61002400; 460027; 3617; 272500; 42002000; 45005600; 11,0004700; 10,0000.69; 0.920.83; 0.98Sereda et al. ([@CR223])Swaziland2001700Okonkwo et al. ([@CR184])Tunisia2400280100039000.42Ennaceur et al. ([@CR80])Tunisia41--31004--32023--12000.81--1.7Ennaceur et al. ([@CR81])Uganda3000Ejobi et al. ([@CR76])Zimbabwe1200--14,000500--9000250--9100150--54001600--25,000810--17,0000.21--0.670.077--0.59Chikuni et al. ([@CR46])Asia, Australia, and the Pacific regionAsia and the Pacific800UNEP ([@CR263])Australia150--8700.06--0.453.6--300.016--0.045Harden et al. ([@CR103])Australia3102800.180.1811120.0350.043Mueller et al. ([@CR165])AustraliaNoakes et al. ([@CR177])Australia890--1000220--2300.22--0.26Quinsey et al. ([@CR200])China1300116513000.051Fujii et al. ([@CR92])China12005.73813000.030Haraguchi et al. ([@CR102])China830; 20001.6; 6.040; 130870; 21000.048; 0.065Kunisue et al. ([@CR141])China560; 7202.2; 4.921; 38580; 7700.038; 0.050Leng et al. ([@CR145])China190018008394120140250021000.0620.079Qu et al. ([@CR199])China2100; 31001900; 3300Sun et al. ([@CR242])China140; 170110; 1203.5; 4.82.6; 2.74.5; 5.03.5; 3.9150; 180120; 1300.029; 0.0330.030; 0.035Tao et al. ([@CR249])China280032031000.12Tsang et al. ([@CR257])China150^a^210^a^Wang et al. ([@CR278])China2500; 2800390; 7000.16; 0.24Wong et al. ([@CR284])China420140847200.20Yao et al. ([@CR287])China1300; 15001100; 1500Zhao et al. ([@CR292])Hong Kong3300Poon et al. ([@CR198])India380--12007.3--2468--210450--15000.18--0.22Devanathan et al. ([@CR67])India56--5660--66170--180Kumar et al. ([@CR140])India980; 10001200; 14002900; 32001.2; 1.3Mishra and Sharma ([@CR163])IndiaSanghi et al. ([@CR210])India9500^a^75^a^2750^a^14,000^a^0.29Siddiqui et al. ([@CR228])India16,800^a^5200^a^3950^a^32000^a^0.24Nair et al. ([@CR168])Indonesia400900.23Burke et al. ([@CR35])Indonesia600--1100140--8601.2--2.80.44--1.232--1808.4--17640--1300160--9100.029--0.160.01--0.071Sudaryanto et al. ([@CR239])Indonesia9406701.30.4739149906700.0410.021Sudaryanto et al. ([@CR240])Iran1300--2900490--11002.0--34170--4806.0--2701600--3600700--14000.13--0.320.0070--0.33Behrooz et al. ([@CR27])Iran170030022000.18Cok et al. ([@CR51])Japan1103.26.71200.062Fujii et al. ([@CR92])Japan92--2501.1--1.74.0--6.997--2600.028--0.43Haraguchi et al. ([@CR102])Japan27017.80.066Konishi et al. ([@CR134])Japan2600.78112800.042Kunisue et al. ([@CR143])Japan72Miyake et al. ([@CR164])Japan92^a^Nagayama et al. ([@CR166])Japan290Nagayama et al. ([@CR167])Jordan260800.30Alawi et al. ([@CR6])Jordan2000-94001960440097002.3Nasir et al. ([@CR170])Kazakhstan20001500Lutter et al. ([@CR157])Kazakhstan1800--3300220--4600.12--0.31Hooper et al. ([@CR108])Korea1204.21401401.2Fujii et al. ([@CR92])Korea1702101800.059Haraguchi et al. ([@CR102])Korea160UNEP ([@CR262])Kuwait8304.2128500.015Saeed et al. ([@CR207])Malaysia160034616000.029Sudaryanto et al. ([@CR238])Philippines56--16030--650.57--1.20.33--0.445.0--7.13.6--5.160--17038--700.045--0.0890.075--0.12Malarvannan et al. ([@CR159])Russia530; 6002.2; 3.650; 52580; 6600.083; 0.098Tsydenova et al. ([@CR258])Saudi Arabia490; 5406.0; 2371; 110570; 6800.14; 0.20Al-Saleh et al. ([@CR10])Saudi Arabia240--1800200; 2602.0--36037--120062; 88280--3300260; 4000.10--0.670.32; 0.34Al-Saleh et al. ([@CR11])Taiwan310233300.074Chao et al. ([@CR45])Thailand7200^a^4200^a^200^a^170^a^2300^a^1700^a^9800^a^5200^a^0.320.41Stuetz et al. ([@CR237])Turkey1900; 200072; 1402200; 27000.036; 0.076Cok et al. ([@CR50])Turkey210011026000.053Cok et al. ([@CR53])Turkey100026014000.24Cok et al. ([@CR55])Turkey15001.81.56516000.043Erdogrul et al. ([@CR82])Turkey6.83.6105.6201137203.03.1Ozcan et al. ([@CR186])Uzbekistan870700.080Ataniyazova et al. ([@CR14])Vietnam12009.45612000.047Haraguchi et al. ([@CR102])Vietnam19007.0; 11170; 2602100; 23000.089; 0.13Minh et al. ([@CR162])Vietnam220; 7201.8; 2.114; 20240; 7500.028; 0.064Nguyen et al. ([@CR173])EuropeBelgium120Colles et al. ([@CR56])Central and Eastern Europe380UNEP ([@CR263])Croatia27228.84.77.12.10.260.10Frkovic et al. ([@CR90])Croatia230; 2602; 514; 190.060; 0.075Kozul and Romanic ([@CR136])Croatia250--490Krauthacker et al. ([@CR138])Croatia100--38013; 1700.12; 0.60Krauthacker et al. ([@CR139])Czech Republic920; 1000820; 86081; 8660; 740.080; 0.0930.073; 0.086Cajka and Hajslova ([@CR36])Czech Republic260--840170--68024--9814--90280--920240--7300.044--0.140.042--0.14Cerna et al. ([@CR40])Czech Republic830-1300(Schoula et al. [@CR220])Denmark59; 1300.31; 0.363.4; 5.763; 1400.042; 0.058Shen et al. ([@CR226])Denmark and Finland908.74.31300.048Damgaard et al. ([@CR60])EnglandThomas et al. ([@CR251])Finland77; 1400.41; 0.484.4; 7.182; 1400.052; 0.056Shen et al. ([@CR225])France80Brucker-Davis et al. ([@CR33])Germany1608741801000.046Raab et al. ([@CR201])Germany240200Schade and Heinzow ([@CR213])Germany360; 380Schlaud et al. ([@CR219])Germany550Skopp et al. ([@CR230])Germany130--17081--110Zietz et al. ([@CR295])Greece72015668000.091Schinas et al. ([@CR218])Italy210--5109.4--440.045--0.10Abballe et al. ([@CR1])Latvia150--24013--220.069--0.12Bake et al. ([@CR24])Norway93--11093--1100.2--0.30.2--0.37.2--107.5100--120100--1200.064--0.110.63--0.10Polder et al. ([@CR196])Norway53; 14041; 61Polder et al. ([@CR197])Poland500--690^a^12--30^a^62--140^a^0.15--0.24Czaja et al. ([@CR59])Poland82063051428706800.0620.066Jaraczewska et al. ([@CR121])Romania35081347000.10Cioroiu et al. ([@CR49])Romania1700^a^1200^a^44^a^29^a^310^a^190^a^2000^a^1400^a^0.190.16Covaci et al. ([@CR57])Russia800; 810680; 7103; 53; 391; 22078; 160900; 1000720; 9200.11; 0.270.12; 0.22Polder et al. ([@CR195])Russia890; 1300900; 12004.1; 8.23.4; 6.51100; 15001000; 1200Polder et al. ([@CR194])Slovak Republic9.0--13001.0--4307.0--1805.0--1100.024--1.20.15--8.0Veningerova et al. ([@CR269])Slovak Republic630; 660540; 54033; 3626; 270.052; 0.0550.048; 0.050Yu et al. ([@CR288])Spain2201.2122400.052Bordajandi et al. ([@CR31])Spain390^a^4.3^a^12^a^0.030Pico et al. ([@CR192])Spain800; 1000Ribas-Fito et al. ([@CR202])Sweden100725.73.70.0560.051Aune et al. ([@CR22])Sweden58; 160524.0; 7.03.70.044; 0.0690.071Bergman et al. ([@CR29])Sweden120786.05.20.0530.067Darnerud ([@CR63])Sweden110Darnerud et al. ([@CR64])Sweden46--72650.98Glynn et al. ([@CR97])Sweden70594.54.2750.0650.072Lignell et al. ([@CR147])Sweden2701009.16.10.0330.060Lignell et al. ([@CR148])Sweden230220.10Lundén and Norén ([@CR156])Sweden250320.13Norén et al. ([@CR180])Sweden84--190821.7--3.21.30.016--0.0220.016Athanasiadou and Bergman ([@CR15])Netherlands55040Albers et al. ([@CR7])Ukraine2300; 2800320; 3400.12; 0.14Gladen et al. ([@CR93])Ukraine25003400.14Gladen et al. ([@CR94])UK43028040250.0930.088Harris et al. ([@CR104])UK1501500.30.36.26.21601600.0410.04Kalantzi et al. ([@CR124])Western Europe and other States82UNEP ([@CR263])Yugoslavia330; 460^a^280; 360^a^12; 360^a^290^a^0.038; 0.790.79Vukavic et al. ([@CR272])The AmericasAntigua and Barbuda190UNEP ([@CR262])Brazil1500618017000.12Paumgartten et al. ([@CR190])Brazil297236046012Azeredo et al. ([@CR23])Canada340Dewailly et al. ([@CR68])Canada960Dewailly et al. ([@CR69])Canada44032024210.0550.065Newsome and Ryan ([@CR171])Canada22093--150^a^2212--18^a^0.100.12--0.14Newsome et al. ([@CR172])Canada and USA180Fitzgerald et al. ([@CR87])Chile210UNEP ([@CR262])GROLAC^b^200UNEP ([@CR263])Mexico2500--1300140; 250Elvia et al. ([@CR79])Mexico530088210078000.40Pardio et al. ([@CR188])Mexico300021031000.069Rodas-Ortiz et al. ([@CR204])Mexico5901609000.27Torres-Arreola et al. ([@CR255])Mexico390070160057000.40Waliszewski et al. ([@CR274])Mexico4000; 48002.0; 5.0650; 9004700; 57000.16; 0.19Waliszewski et al. ([@CR276])Nicaragua28001300.046Romero et al. ([@CR206])Uruguay130UNEP ([@CR262])USA190Fitzgerald et al. ([@CR87])USA270260Greizerstein et al. ([@CR99])USA53353.12.76.765410.13Johnson-Restrepo et al. ([@CR122])USA220Kostyniak et al. ([@CR135])USA12050.041Pan et al. ([@CR187])USA110; 440^a^79; 87^a^3.1; 9.4^a^2.6; 2.7^a^120; 460^a^83; 91^a^0.021; 0.0270.029; 0.033Weldon et al. ([@CR279])Venezuela280--1000^a^Brunetto et al. ([@CR34])When concentrations from more than one sampling site in the same country and study have been reported, the concentrations are given as two values separated by a semicolon ";" (two concentrations) or a dash "--" (for more than two concentrations)^a^Recalculated from fresh weight, assuming 4 % fat content^b^Group of Latin America and Caribbean countriesTable 3Concentrations (ng/g fat) of CB-153, ∑ 6 indicator PCBs, and ∑PCBs, in mothers' milk, as reported in studies from around the world, 1995--2011RegionCountryCB-153∑ 6 indicator PCBs^a^∑PCBReferenceMeanMedianMeanMedianMeanMedianGMAfricaAfrica31UNEP ([@CR263])Ghana6.4--225.4--1930--8226--72Asante et al. ([@CR13])South Africa2.62108.4Darnerud et al. ([@CR65])Tunisia18--12095--660110--750Ennaceur et al. ([@CR81])Zimbabwe2.8--60Chikuni et al. ([@CR46])Asia, Australia, and the Pacific regionAsia and the Pacific15UNEP ([@CR263])Australia160--480Quinsey et al. ([@CR200])Cambodia20--2913--24Kunisue et al. ([@CR141])China28--42Kunisue et al. ([@CR141])China74Poon et al. ([@CR198])China1449Tsang et al. ([@CR257])China33; 42Wong et al. ([@CR284])China9.5Xing et al. ([@CR285])China0.49--162.4--29Zhang et al. ([@CR291])China13.28210210Zhao et al. ([@CR292])India23--40Devanathan et al. ([@CR67])Indonesia21--3317--27Sudaryanto et al. ([@CR239])Iran200--25046--150990--1900130--1000Behrooz et al. ([@CR27])Japan120110Kawashiro et al. ([@CR128])Japan200Konishi et al. ([@CR134])Japan120Kunisue et al. ([@CR143])Japan120100Nakamura et al. ([@CR169])Japan110Nagayama et al. ([@CR166])Japan191839367367Todaka et al. ([@CR254])Jordan2542Alawi et al. ([@CR6])Kazakhstan100--430220--820Hooper et al. ([@CR108])Kazakhstan100--350410Lutter et al. ([@CR157])Kazakhstan6550180130370290She et al. ([@CR224])Malaysia14; 80Sudaryanto et al. ([@CR238])Russia160--240Tsydenova et al. ([@CR258])Taiwan5554Wang et al. ([@CR277])Philippines50--7040--60Malarvannan et al. ([@CR159])Turkey112627Cok et al. ([@CR55])Turkey110190210Cok et al. ([@CR52])Turkey3.4--1111--1918--36Cok et al. ([@CR54])Turkey8.5^b^8.2^b^27^b^28^b^Erdogrul et al. ([@CR82])Turkey126.510069Ozcan et al. ([@CR186])Vietnam11--4356--150Haraguchi et al. ([@CR102])Vietnam74; 79Minh et al. ([@CR162])Vietnam5.7; 8.233; 4624; 33Tue et al. ([@CR259])Vietnam4.7; 8.114; 2233; 47Nguyen et al. ([@CR173])EuropeBelgium4397110Colles et al. ([@CR56])Central and Eastern Europe47UNEP ([@CR263])Croatia39; 42110; 110120; 130Kozul and Romanic ([@CR136])Croatia210Krauthacker et al. ([@CR138])Croatia29120Krauthacker et al. ([@CR139])Croatia10110140Zubcic and Krauthacker ([@CR296])Czech Republic220; 420530; 1100620; 1200Bencko et al. ([@CR28])Czech Republic260; 300220; 260940; 1100780; 900Cajka and Hajslova ([@CR36])Czech Republic93--90098--650300--2000310--1500490--4900480--3400Cerna et al. ([@CR40])Czech Republic270--480860--1100Schoula et al. ([@CR220])Finland88; 110350; 440Vartiainen et al. ([@CR268])France59170Brucker-Davis et al. ([@CR33])Germany550500Schade and Heinzow ([@CR213])Germany540; 1300Schlaud et al. ([@CR219])Germany140310Skopp et al. ([@CR230])Germany90210Wittsiepe et al. ([@CR283])Germany200180Zietz et al. ([@CR295])Italy54120200Alivernini et al. ([@CR9])Italy110110280280Riva et al. ([@CR203])Italy22--3850--9282--130Ulaszewska et al. ([@CR260])Latvia16--24110--170Bake et al. ([@CR24])Lithuania130--160290--360400--480Becher et al. ([@CR26])Netherlands77240270Albers et al. ([@CR7])Netherlands120--140300--350360--410van den Berg et al. ([@CR265])Norway130--140270; 300330--380Becher et al. ([@CR26])Norway99Eggesbo et al. ([@CR73])Norway44--5352100--120100--120160--180160--200Polder et al. ([@CR196])Norway110; 120100; 110Polder et al. ([@CR197])Poland190--550^b^Czaja et al. ([@CR58])Poland4035150130Jaraczewska et al. ([@CR121])Poland170--350Pietrzak-Fiecko et al. ([@CR193])Poland30; 3856; 7782;97Skrbic et al. ([@CR231])Romania58^b^37^b^9.76.5Covaci et al. ([@CR57])Russia120; 130110; 12030--23020--210300--350290; 330Polder et al. ([@CR194])Russia50; 9050; 50120; 200100; 180190; 350180; 320Polder et al. ([@CR195])Serbia26^b^11^b^76^b^27^b^81^b^31^b^Vukavic et al. ([@CR273])Slovak Republic230--480540--1200590--1300Petrik et al. ([@CR191])Slovak Republic200; 200180; 180600; 650500; 540Yu et al. ([@CR288])Spain280Schuhmacher et al. ([@CR222])Sweden42--705187--140100120--180140Athanasiadou and Bergman ([@CR15])Sweden100240Atuma et al. ([@CR21])Sweden5148140130Aune et al. ([@CR22])Sweden29; 302799; 10098Bergman et al. ([@CR29])Sweden5655110110148144Darnerud ([@CR63])Sweden64Darnerud et al. ([@CR64])Sweden7469150136170160Glynn et al. ([@CR95])Sweden31--4880--120Glynn et al. ([@CR97])Sweden61190Guvenius et al. ([@CR101])Sweden4743120110Lignell et al. ([@CR147])Sweden6257150140Lignell et al. ([@CR148])Sweden5852140120Lignell et al. ([@CR150])Sweden58110Lignell et al. ([@CR151])Sweden96200380Lundén and Norén ([@CR156])Sweden96410Norén et al. ([@CR180])Switzerland3628290240Zehringer and Herrmann ([@CR290])Ukraine600Gladen et al. ([@CR94])Ukraine490; 680Gladen et al. ([@CR93])UK49180150Kalantzi et al. ([@CR124])Western Europe and other States79UNEP ([@CR263])Former Yugoslavia11; 204.9; 8.2Vukavic et al. ([@CR272])The AmericasBrazil37150Paumgartten et al. ([@CR190])Canada54130Dewailly et al. ([@CR68])Canada620Dewailly et al. ([@CR69])Canada3833.4240210Newsome et al. ([@CR172])Canada250240Newsome and Ryan ([@CR171])Canada and USA50220Fitzgerald et al. ([@CR86])GROLAC^c^28UNEP ([@CR263])Mexico1101500Rodas-Ortiz et al. ([@CR204])USA33120Fitzgerald et al. ([@CR86])USA6965300280Greizerstein et al. ([@CR99])USA57^d^270Kostyniak et al. ([@CR135])USA1777Pan et al. ([@CR187])USA91Park et al. ([@CR189])USA1.5; 9.0^b^1.1; 6.0^b^22; 29^b^19; 20^b^Weldon et al. ([@CR279])When concentrations from more than one sampling site in the same country and study have been reported, the concentrations are given as two values separated by a semicolon ";" (two concentrations) or a dash "--" (for more than two concentrations)^a^Sum of CB-28, CB-52, CB-101, CB-138, CB-153, and CB-180^b^Recalculated from fresh weight, assuming 4 % fat content^c^Group of Latin America and Caribbean countries^d^Reported as the sum of CB-105, CB-132, and CB-153Table 4Concentrations (ng/g fat) of hexachlorobenzene (HCB) and the three HCH isomers, α-HCH, β-HCH, and γ-HCH, in mothers' milk, as reported in studies from around the world, 1995--2011, are presented. Also the ∑HCH data are presented, giving data as reported in the studies referred toRegionCountryHCBα-HCHβ-HCHγ-HCHδ-HCH∑HCHsReferenceMeanMedianGeo. meanMeanMedianGeo. meanMeanMedianGeo. meanMeanMedianGeo. meanMeanMedianGeo. meanMeanMedianGeo. meanAfricaAfrica2.8UNEP ([@CR263])Egypt210^a^210Saleh et al. ([@CR209])Ghana4.91901446Darko and Acquaah ([@CR62])Ghana40Ntow ([@CR181])Ghana2.5--143.5--65UNEP ([@CR262])Libya140240120500Elafi et al. ([@CR77])Nigeria5.029UNEP ([@CR262])Senegal3.765UNEP ([@CR262])South Africa1.91.8124.3Darnerud et al. ([@CR65])SwazilandOkonkwo et al. ([@CR184])Tunisia0.38--29016--1103--7026--130Ennaceur et al. ([@CR81])Tunisia2605067Ennaceur et al. ([@CR80])UgandaEjobi et al. ([@CR76])Asia, Australia, and the Pacific regionAsia and the Pacific1.25UNEP ([@CR263])Australia6.6--7614.30.03--0.180.0477.6--660210.08--.470.227.7--66021Harden et al. ([@CR103])Australia30190.180.1324270.20.22427Mueller et al. ([@CR165])AustraliaNoakes et al. ([@CR177])Australia370--46061--85200--550100--130100--130500--900Quinsey et al. ([@CR200])Australia51359.89.8Khanjani and Sim ([@CR130])Cambodia1.6; 1.81.4; 1.54.8; 5.63.5; 3.6Kunisue et al. ([@CR141])China56; 814.7; 5.0550; 14000.93; 1.3550; 1400Kunisue et al. ([@CR141])China19; 483.7240; 6301.8; 1.8240; 640Leng et al. ([@CR145])China5.33.955424.52.94.31.58055Qu et al. ([@CR199])China88; 10085; 9810; 18021; 110Sun et al. ([@CR242])China950; 1100Wong et al. ([@CR284])China6449.555.6170Yao et al. ([@CR287])China0.80; 1.40.67; 1.0310; 360210; 2802.32.40.910.72310; 360210; 290Yu et al. ([@CR289])China38; 4833; 4725; 7618; 53160; 210200; 2106.0; 178.0; 14190; 350260; 270Zhao et al. ([@CR292])China33230Zhou et al. ([@CR294])Hong Kong1000Poon et al. ([@CR198])Hong Kong and China220.69401.8940Hedley et al. ([@CR106])India18008800230013,000Banerjee et al. ([@CR25])India1.7--4.44.6--9.1210--6801.1--82220--670Devanathan et al. ([@CR67])India32--3739--4351--54120--130Kumar et al. ([@CR140])India640; 8301000; 1100600; 62077; 1702700; 2300Mishra and Sharma ([@CR163])India1100^a^5000^a^2100^a^8200^a^Nair et al. ([@CR168])India1600^a^900^a^100^a^2600^a^Sanghi et al. ([@CR210])India1800^a^16,000^a^1300^a^2300^a^22,000^a^Siddiqui et al. ([@CR228])Indonesia609090Burke et al. ([@CR35])Indonesia1.8--2.31.6--2.30.02--0.220.08; 0.186.6--315.4--9.00.26--1.20.12; 0.227--305.5--8.3Sudaryanto et al. ([@CR239])Indonesia2.11.80.18126.30.680.08126.8Sudaryanto et al. ([@CR240])Iran630--1500280--820880--1700420--13001600--4000910--15,000126--46070--2402600--57001400--17,000Behrooz et al. ([@CR27])Iran6122400180600Cok et al. ([@CR51])Japan14210210Konishi et al. ([@CR134])Japan130.489292Kunisue et al. ([@CR143])Japan72828Miyake et al. ([@CR164])Japan0.181.2Nagayama et al. ([@CR166])Japan330330Nagayama et al. ([@CR167])Japan346363Saito et al. ([@CR208])Jordan618239039510Alawi et al. ([@CR6])Jordan350180710890Nasir et al. ([@CR170])Kazakhstan73--9771--801700--23001400--1800Lutter et al. ([@CR157])Kazakhstan52--18041--971600--35001600--3500Hooper et al. ([@CR108])Korea7.720UNEP ([@CR262])Kuwait0.693.61.15.4Saeed et al. ([@CR207])Malaysia1112301.3230Sudaryanto et al. ([@CR238])Philippines1.7--2.51.5--1.90.24--0.290.17--0.253.2--4.92.7--4.00.15--0.340.14--0.163.6--5.53.1--4.3Malarvannan et al. ([@CR159])Taiwan1.91.53.4Chao et al. ([@CR45])Thailand130^a^140^a^90^a^Stuetz et al. ([@CR237])Turkey44--5850--67360--42016--17440--480Cok et al. ([@CR50])Turkey3911508160Cok et al. ([@CR55])Turkey732728014340Cok et al. ([@CR53])Turkey201503150Erdogrul et al. ([@CR82])Turkey5.92.55.90142.8108.045.012332Ozcan et al. ([@CR186])Uzbekistan2876110081200Ataniyazova et al. ([@CR14])Vietnam7.4--8649--570Haraguchi et al. ([@CR102])Vietnam2.5; 3.914; 58Minh et al. ([@CR162])Vietnam1.8; 3.00.205.1; 180.0555.8; 18Nguyen et al. ([@CR173])EuropeBelgium16.2Colles et al. ([@CR56])Central and Eastern Europe3.1UNEP ([@CR263])Croatia4.24.01.11.1Frkovic et al. ([@CR90])Croatia7.4--121.5--2.419--2015--1836--41Romanic and Krauthacker ([@CR205])Croatia11--3124--3926--40Krauthacker et al. ([@CR138])Croatia5--13212--547--1424--62Krauthacker et al. ([@CR139])Czech Republic320; 420250; 37056; 6455; 5756; 6455; 57Cajka and Hajslova ([@CR36])Czech Republic119--74892--35722--3620--27Cerna et al. ([@CR40])Czech Republic480--64071--80Schoula et al. ([@CR220])Denmark120.51180.740.06740740Shen et al. ([@CR225])Denmark120.26170.650.0418Shen et al. ([@CR226])Finland8.40.19120.610.04860660Shen et al. ([@CR225])Finland8.00.16110.40.0312Shen et al. ([@CR225])Finland and Denmark100.191313Damgaard et al. ([@CR60])France23Brucker-Davis et al. ([@CR33])Germany2721178178Raab et al. ([@CR201])Germany807040404040Schade and Heinzow ([@CR213])Germany150; 22045; 5912; 1661; 71Schlaud et al. ([@CR219])Germany27; 3823; 3121; 2712; 171.7; 3.7322--3012--20Zietz et al. ([@CR295])Greece6.015.517.06.859Schinas et al. ([@CR218])Italy38--70Abballe et al. ([@CR1])Latvia19--320.18--0.2742--900.06--0.3442--90Bake et al. ([@CR24])Norway1212Eggesbo et al. ([@CR74])Norway17--1918--200.2--0.20.2--0.210--169.2--140.3--0.70.3--0.510--179.7--14Polder et al. ([@CR196])Norway11; 1511; 135.4; 184.7; 8.1Polder et al. ([@CR197])Poland33--55^a^5.0--20^a^35--100^a^5--12^a^45--130^a^Czaja et al. ([@CR59])Poland322913.3110.81411Jaraczewska et al. ([@CR121])Romania204327.57545190Cioroiu et al. ([@CR49])Romania16^a^14^a^17^a^15^a^480^a^440^a^35^a^15^a^520^a^440^a^Covaci et al. ([@CR57])Russia58; 6555; 583.0; 3.22.0; 3.0180; 230160; 1900.5; 2.00.5; 1.0240200Polder et al. ([@CR195])Russia110; 13093;1104.5; 5.63.8; 5.7740; 850620; 6600.4; 0.70.3; 0.7750; 860620; 660Polder et al. ([@CR194])Russia100; 13010; 18800; 10000.45; 0.58810; 1000Tsydenova et al. ([@CR258])Serbia11; 38^a^13; 56^a^33; 50^a^29; 38^a^110; 190^a^100; 130^a^Vukavic et al. ([@CR272])Slovak Republic19--2405.0--17011--8710--652.0--121.0--7.018--9514--70Veningerova et al. ([@CR269])Slovak Republic98; 10279; 8019; 2015; 1619; 2015; 16Yu et al. ([@CR288])Spain340^a^8.3^a^Pico et al. ([@CR192])Spain630; 910Ribas-Fito et al. ([@CR202])Sweden11.711.8159.6159.6Aune et al. ([@CR22])Sweden8.2; 117.76.4; 326.3Bergman et al. ([@CR29])Sweden15.113.71510159.7Darnerud ([@CR63])Sweden9.48.87.97.27.97.2Lignell et al. ([@CR147])Sweden151414121412Lignell et al. ([@CR148])Sweden31Lundén and Norén ([@CR156])SwedenNorén et al. ([@CR180])Sweden6.3--8.53.5--6.4Athanasiadou and Bergman ([@CR15])Netherlands10080Albers et al. ([@CR7])Ukraine150; 190710; 750Gladen et al. ([@CR93])Ukraine168730730Gladen et al. ([@CR94])UK432568506850Harris et al. ([@CR104])UK18170.217150.60.81618Kalantzi et al. ([@CR124])Western Europe and other States2.3UNEP ([@CR263])The AmericasAntigua and Barbuda5.35UNEP ([@CR262])Brazil1212705280Paumgartten et al. ([@CR190])CanadaDewailly et al. ([@CR68])Canada107Dewailly et al. ([@CR69])Canada43434.41.618210.760.662323Newsome and Ryan ([@CR171])Canada158--12^a^0.312312--16^a^1.02419Newsome et al. ([@CR172])Canada and USA12Fitzgerald et al. ([@CR87])Chile116.4UNEP ([@CR262])Mexico60--160160--230280--320Elvia et al. ([@CR79])MexicoPardio et al. ([@CR188])Mexico92310610380240750Rodas-Ortiz et al. ([@CR204])Mexico531943084530Waliszewski et al. ([@CR274])Mexico25; 4120; 351.0; 4.061; 9044; 662; 463; 9948; 74Waliszewski et al. ([@CR275])Mexico302060406050Sun et al. ([@CR243])Nicaragua6.017Romero et al. ([@CR206])Uruguay14.30UNEP ([@CR262])USA15.15Greizerstein et al. ([@CR99])USA2.31.61.71.47.74.47.65.11.91913Johnson-Restrepo et al. ([@CR122])USA14Fitzgerald et al. ([@CR87])USA9.6Kostyniak et al. ([@CR135])USA5.8; 6.6^a^4.8; 5.6^a^7.8; 14^a^5.5; 11^a^Weldon et al. ([@CR279])When concentrations from more than one sampling site in the same country and study have been reported, the concentrations are given as two values separated by a semicolon ";" (two concentrations) or a dash "--" (for more than two concentrations)^a^Recalculated from fresh weight, assuming 4 % fat contentTable 5Concentrations (ng/g fat) of oxychlordane, α-chlordane, γ-chlordane, and ∑chlordanes, in mothers' milk, as reported in studies from around the world, 1995--2011, are presentedRegionCountryOxychlordaneα-Chlordaneγ-Chlordane∑ChlordanesReferenceMeanMedianMeanMedianMeanMedianMeanMedianAfricaAfrica4.1UNEP ([@CR263])Ghana1.2UNEP ([@CR262])Nigeria2.4UNEP ([@CR262])Senegal11.7UNEP ([@CR262])Asia and the Pacific regionAsia and the Pacific3.6UNEP ([@CR263])Australia7.67Khanjani and Sim ([@CR130])Australia2.8--18Harden et al. ([@CR103])Australia5.15.15.55.4Mueller et al. ([@CR165])Australia140; 150Quinsey et al. ([@CR200])Australia7Sim et al. ([@CR229])China0.49Haraguchi et al. ([@CR102])China2.9; 8Kunisue et al. ([@CR141])China1.0; 1.01.2Leng et al. ([@CR145])Hong Kong and China6.16.1Hedley et al. ([@CR106])India2.6--3.4Devanathan et al. ([@CR67])Indonesia0.49--2.40.49--0.737.0--305.5--8.3Sudaryanto et al. ([@CR239])Japan3--4.8Haraguchi et al. ([@CR102])Japan85Konishi et al. ([@CR134])Japan1458Kunisue et al. ([@CR143])Japan0.76Nagayama et al. ([@CR166])Jordan460590Nasir et al. ([@CR170])Korea5.1Haraguchi et al. ([@CR102])Korea3.7UNEP ([@CR262])Malaysia7.1Sudaryanto et al. ([@CR238])Taiwan10Chao et al. ([@CR45])Philippines1.7--3.01.6--2.50.59--1.40.52--0.60Malarvannan et al. ([@CR159])Turkey7^a^5^a^Erdogrul et al. ([@CR82])Vietnam0.047Haraguchi et al. ([@CR102])Vietnam0.9; 2.40.8; 1.11.5; 3.72; 6.9Minh et al. ([@CR162])Vietnam0.26; 0.510.4; 0.96Nguyen et al. ([@CR173])EuropeCentral and Eastern Europe1.85UNEP ([@CR263])Denmark5.10.030.05Shen et al. ([@CR225])Denmark4.70.030.05Shen et al. ([@CR226])Finland4.00.020.04Shen et al. ([@CR225])Finland3.60.020.03Shen et al. ([@CR226])Finland and Denmark4.30.050Damgaard et al. ([@CR60])Germany54Raab et al. ([@CR201])Germany8.8Skopp et al. ([@CR230])Norway3.6--4.93.9--5.01.6--2.31.4--2.5Polder et al. ([@CR196])Norway3.0; 4.42.8; 3.2Polder et al. ([@CR197])Poland3.32.8Jaraczewska et al. ([@CR121])Russia5; 65; 51; 31; 221; 2216; 20Polder et al. ([@CR195])Russia3.9; 5.610; 19Tsydenova et al. ([@CR258])Russia7.9; 8.13.3; 6.93; 5.433; 5921; 52Polder et al. ([@CR194])Sweden2.5--3.52.4; 3.4Athanasiadou and Bergman ([@CR15])Sweden4.43.6Darnerud ([@CR63])Sweden3.33.1Lignell et al. ([@CR147])Sweden4.43.8Lignell et al. ([@CR148])Ukraine16; 22Gladen et al. ([@CR93])Ukraine18Gladen et al. ([@CR94])UK0.3Kalantzi et al. ([@CR124])Western Europe and other States3.6UNEP ([@CR263])The AmericasAntigua and Barbuda4.4UNEP ([@CR262])Canada59431.3Newsome and Ryan ([@CR171])Canada137.8--13^a^0.210.16Newsome et al. ([@CR172])Chile2UNEP ([@CR262])GROLAC^b^4.4UNEP ([@CR263])Mexico30--40Elvia et al. ([@CR79])Mexico260930970Rodas-Ortiz et al. ([@CR204])Uruguay4.4UNEP ([@CR262])USA173.82.71.21.1Johnson-Restrepo et al. ([@CR122])When concentrations from more than one sampling site in the same country and study have been reported, the concentrations are given as two values separated by a semicolon ";" (two concentrations) or a dash "--" (for more than two concentrations)^a^Recalculated from fresh weight, assuming 4 % fat content^b^Group of Latin America and Caribbean countriesTable 6Concentrations (pg TEQs/g fat) PCDDs/PCDFs and DL-PCBs, in mothers' milk, as reported in studies from around the world, 1995 -- 2011 are presented^a^. Also the ∑TEQs levels are presented, giving data as reported in the studies referred toRegionCountry∑PCDD/F∑DL-PCBTotal-TEQmeanmedianmeanmeanmeanmedian(TEQ1998)(TEQ2005)(TEQ1998)(TEQ2005)(TEQ1998)(TEQ2005)(TEQ1998)(TEQ2005)(TEQ1998)Reference**Africa**Africa3.6(UNEP 2011)Ghana3.2(UNEP 2009)Nigeria3.1(UNEP 2009)Senegal7.2(UNEP 2009)**Asia and the Pacific region**Asia & the Pacific4.5(UNEP 2011)China159.0(Chan et al. 2007)China2.9-162.4-13(Li et al. 2009)China4.93.93.32.38.26.2(Sun et al. 2011)China4.4-6.21.9-3.96.2-7.5(Sun et al. 2010)China0.120.29(Zheng et al. 2003)China17; 1723(Sun et al. 2005)Hong Kong8.27.213(Hedley et al. 2006)Japan131121(Kunisue et al. 2006)Japan0.28(Nagayama et al. 2007a)Japan119.719(Nakamura et al. 2008)Japan1910672518(Saito et al. 2005)Japan17156.85.52421(Suzuki et al. 2005)Japan1513112613(Tajimi et al. 2005)Japan6.91.14.63.4118.6(Todaka et al. 2011)Japan23(Nagayama et al. 2007b)Kazakhstan23; 4621; 45(Hooper et al. 1998)Korea4.0(UNEP 2009)Korea10; 238.9; 214.8; 6.13.5; 4.815; 2912; 25(Yang et al. 2002)Taiwan7.4; 120.73; 6.612(Chao et al. 2005)Taiwan1513(Hsu et al. 2007)Taiwan7.613(Wang et al. 2004)Turkey4.9-123.9-106.8-16(Cok et al. 2009)Uzbekistan22(Ataniyazova et al. 2001)Vietnam2.7; 6.6(Nhu et al. 2011)Vietnam0.086; 0.130.073-0.12(Tawara et al. 2011)**Europe**Belgium2916324142(Focant et al. 2002)Central &Eastern Europe5.9(UNEP 2011)Czech Rep.13; 209.8; 156.0-9.84.7-8.619-3015-23(Bencko et al. 1998)Faroe Islands363114145046(Grandjean et al. 1995)Finland8.6; 1214; 19(Alaluusua et al. 2002)Finland21; 2619; 2322; 2913; 1943; 5532; 42(Vartiainen et al. 1997)Germany9.84.92014(Raab et al. 2008)Germany14112711(Wittsiepe et al. 2007)Italy9.4-157.8-1220-34(Abballe et al. 2008)Italy4.6-6.13.8-4.96.2-6.94.8-5.711-138.6-11(Ulaszewska et al. 2011)Latvia7.1-125.8-9.2170; 190170; 200(Bake et al. 2007)Lithuania14-1812-1530-3016-1744-4828-31(Becher et al. 1995)Norway9.7-138.2-1118-309.3-2029-4018-29(Becher et al. 1995)Russia16; 287.2; 9.527; 28(Schecter et al. 2002)Slovak Rep.5.7-124.5-9.014-24(Chovancova et al. 2011)Spain10.9(Bordajandi et al. 2008)Spain7.6916.6(Schuhmacher et al. 2009)Sweden131113122624(Atuma et al. 1998)Sweden913(Darnerud et al. 2010)Sweden8.87.619(Glynn et al. 2001)Sweden8.16.97.46.48.15.6161315(Glynn et al. 2007)Sweden8.27.01613(Lignell et al. 2009a)Sweden211520134028(Lundén and Norén 1998)Sweden3.52.93.62.27.05.0(Fång et al. 2013)Western Europe & other States6.0(UNEP 2011)**The Americas**Antigua & Barbuda4.3(UNEP 2009)Brazil10104.40.601411(Paumgartten et al. 2000)Canada4.9-143.3-8.36.5-18(Newsome & Ryan 1999)Chile9.7(UNEP 2009)GROLAC^a^5.6(UNEP 2011)Uruguay6.9(UNEP 2009)**Country∑PCDD/F∑PCDD/F∑PCDD/F∑PCDD/FTotal-TEQTotal-TEQ(mean,TEQ1998)(mean,TEQ2005)(mean, I-TEQ)(CALUX-TEQ)(CALUX-TEQ)(EROD-TEQ)**Brazil^b^108.1(Paumgartten et al. 2000)China9.4; 1314; 15(Leng et al. 2009)China^b^0.120.291.0(Zheng et al. 2003)Hong Kong18(Tsang et al. 2009)Germany20; 23(Schlaud et al. 1995)Kazakhstan^b^23; 4620; 40(Hooper et al. 1998)Spain1210(Schuhmacher et al. 2004)^a^When concentrations from more than one sampling site in the same country and study have been reported the concentrations are given as two values separated by a semicolon ";" (two concentrations) or a hyphen "--" (for more than two concentrations)^b^Included for comparison with WHO TEQs, not unique samples^c^Group of Latin America and Caribbean CountriesTable 7Concentrations (ng/g fat) of BDE-47, BDE-209, and ∑PBDE, in mothers' milk, as reported in studies from around the world, 1995--2011, are presentedRegionBDE-47BDE-209∑PBDEReferenceCountryMeanMedianGeo. meanMeanMedianMeanMedianGeo. meanAfricaGhana0.77--2.10.49--1.70.83--1.40.39--0.952.2--5.81.3--4.3Asante et al. ([@CR13])South Africa0.290.31.71.4Darnerud et al. ([@CR65])Asia and the Pacific regionChina0.891.9Haraguchi et al. ([@CR102])China0.33; 0.660.32; 0.620.95; 1.31.84.7; 7.72.8; 7.1Sudaryanto et al. ([@CR241])China0.23--0.740.22--0.710.22--0.700.22--0.573.4--4.22.2--4.1Sun et al. ([@CR243])China0.21--0.730.85--3.0Zhang et al. ([@CR291])Hong Kong and South China1.93.4Hedley et al. ([@CR106])Indonesia0.22--0.580.53; 0.540.91--1.8Sudaryanto et al. ([@CR240])Japan0.371.4Akutsu et al. ([@CR4])Japan190.58311.5Akutsu and Hori ([@CR3])Japan0.57--0.761.3--1.7Haraguchi et al. ([@CR102])Japan2.1^a^0.43^a^4.63Kawashiro et al. ([@CR128])Korea23.7Haraguchi et al. ([@CR102])Korea1.22.7Kim et al. ([@CR132])Philippines1.2; 4.91.1; 1.21.81.82.6; 102.7; 4.2Malarvannan et al. ([@CR159])Taiwan0.580.520.480.363.53.3Koh et al. ([@CR133])Turkey0.15^a^0.1^a^0.2^a^0.1^a^Erdogrul et al. ([@CR82])Turkey6.03.36743Ozcan et al. ([@CR186])Vietnam0.190.42Haraguchi et al. ([@CR102])Vietnam0.13; 0.400.57; 2.31.1; 4.0Tue et al. ([@CR259])EuropeCzech Republic0.860.61Kazda et al. ([@CR129])France1.52.7Antignac et al. ([@CR12])Germany0.670.482.01.6Raab et al. ([@CR201])Italy0.821.3Alivernini et al. ([@CR9])Norway1.70.950.50.253.31.9Eggesbo et al. ([@CR75])Norway1.71.30.220.133.83.2Polder et al. ([@CR196])Norway1.70.323.42.1Thomsen et al. ([@CR252])Poland1.10.732.52Jaraczewska et al. ([@CR121])Russia0.43; 0.650.36; 0.580.350.191.1; 1.20.96; 1.1Polder et al. ([@CR195])Russia0.96Tsydenova et al. ([@CR258])Spain0.33Bordajandi et al. ([@CR31])Spain2.5Schuhmacher et al. ([@CR222])Sweden1.6; 20.2; 1.53.9; 4.8Athanasiadou and Bergman ([@CR15])Sweden1.791.33.02.4Aune et al. ([@CR22])Sweden0.93; 2.40.710.662.1; 4.31.9Bergman et al. ([@CR29])Sweden1.91.73.23.2Darnerud ([@CR63])Sweden0.922.4Fängström et al. ([@CR85])Sweden1.2--1.82.2--3.3Glynn et al. ([@CR97])Sweden1.2Guvenius et al. ([@CR101])Sweden1.81.33.42.8Lignell et al. ([@CR147])Sweden1.20.76Lignell et al. ([@CR150])Sweden1.91.53.52.9Lignell et al. ([@CR149])Sweden1.51.52.62.5Lind et al. ([@CR152])Sweden2.34.0Meironyté et al. ([@CR161])UK2.73.06.36.6Kalantzi et al. ([@CR124])The AmericasUSA2851Daniels et al. ([@CR61])USA417.77520Johnson-Restrepo et al. ([@CR122])USA733.71.4130Park et al. ([@CR189])USA41180.927434Schecter et al. ([@CR215])USA36171.40.106630Schecter et al. ([@CR216])USA36247640Schecter et al. ([@CR217])When concentrations from more than one sampling site in the same country and study are reported, the concentrations are given as two values separated by a semicolon (two concentrations) or a dash (for more than two levels)^a^Recalculated from fresh weight, assuming 4 % fat contentTable 8Concentrations (ng/g fat) of *cis*-HCL-epoxide, HCL-epoxide, and heptachlor, in mothers' milk, as reported in studies from around the world, 1995--2011, are presentedRegionCountry*cis*-HCL-epoxideHCL-epoxideHeptachlorReferenceMeanMeanMedianMeanMedianAfricaAfrica2.25UNEP ([@CR263])Ghana0.9UNEP ([@CR262])Nigeria0.9UNEP ([@CR262])Senegal1.3UNEP ([@CR262])Asia and the Pacific regionAsia and the Pacific0.55UNEP ([@CR263])Australia2.2--177.4Harden et al. ([@CR103])Australia5.96Mueller et al. ([@CR165])Australia53; 78Quinsey et al. ([@CR200])Australia7Sim et al. ([@CR229])Australia9.97Khanjani and Sim ([@CR130])China0.7Hedley et al. ([@CR106])Iran54Cok et al. ([@CR51])Japan7.5Konishi et al. ([@CR134])Japan7.4Saito et al. ([@CR208])Japan3Nagayama et al. ([@CR166])Jordan190500Nasir et al. ([@CR170])Korea2.2UNEP ([@CR262])Kuwait1.3Saeed et al. ([@CR207])Taiwan4.33Chao et al. ([@CR45])Thailand160^a^110^a^110^a^110^a^Stuetz et al. ([@CR237])Turkey61Cok et al. ([@CR53])Turkey38Cok et al. ([@CR55])EuropeCentral and Eastern Europe0.50UNEP ([@CR263])Croatia0.7Frkovic et al. ([@CR90])Denmark2.9Shen et al. ([@CR226])Denmark2.8Shen et al. ([@CR225])Denmark and Finland2.3Damgaard et al. ([@CR60])Finland2.0Shen et al. ([@CR226])Finland2.2Shen et al. ([@CR225])Germany43Raab et al. ([@CR201])Germany21; 22Schlaud et al. ([@CR219])Germany0.11Zietz et al. ([@CR295])Germany7.3Skopp et al. ([@CR230])Netherlands30Albers et al. ([@CR7])Spain9^a^Pico et al. ([@CR192])Ukraine22Gladen et al. ([@CR93])Ukraine16Gladen et al. ([@CR94])The AmericasAntigua and Barbuda1.4UNEP ([@CR262])Brazil8Paumgartten et al. ([@CR190])Canada0.94Newsome and Ryan ([@CR171])Canada3.80.75--3.2^a^Newsome et al. ([@CR172])Chile1.7UNEP ([@CR262])GROLAC^b^1.4UNEP ([@CR263])Mexico40Elvia et al. ([@CR79])Mexico160580Rodas-Ortiz et al. ([@CR204])Nicaragua61Romero et al. ([@CR206])Uruguay1UNEP ([@CR262])Western Europe and other States0.8UNEP ([@CR263])When concentrations from more than one sampling site in the same country and study have been reported, the concentrations are given as two values separated by a semicolon ";" (two concentrations) or a dash "--" (for more than two concentrations)^a^Recalculated from fresh weight, assuming 4 % fat content^b^Group of Latin America and Caribbean countriesTable 9Concentrations (ng/g fat) of aldrin, dieldrin, endrin, and ∑drins, in mothers' milk, as reported in studies from around the world, 1995--2011, are presentedRegionCountryAldrinDieldrinEndrin∑drinsReferenceMeanMedianMeanMedianGeo. meanMeanMedianMeanAfricaAfrica2.8UNEP ([@CR263])Ghana120Ntow et al. ([@CR182])Ghana1.3UNEP ([@CR262])Nigeria4.1UNEP ([@CR262])Senegal3.1UNEP ([@CR262])Tunisia25Ennaceur et al. ([@CR81])Tunisia5936Ennaceur et al. ([@CR80])Asia and the Pacific regionAsia and the Pacific1.8UNEP ([@CR263])Australia5140Khanjani and Sim ([@CR130])Australia0.01--0.6815Harden et al. ([@CR103])Australia0.190.051614Mueller et al. ([@CR165])Australia25^a^Noakes et al. ([@CR177])Australia150; 160Quinsey et al. ([@CR200])Australia39Sim et al. ([@CR229])China9300--10,000^a^Wang et al. ([@CR278])China7.9Zhou et al. ([@CR294])China and Hong Kong1.1Hedley et al. ([@CR106])India250^a^Siddiqui et al. ([@CR228])Japan28Konishi et al. ([@CR134])Japan3Nagayama et al. ([@CR166])Jordan86014003300Nasir et al. ([@CR170])Korea1.3UNEP ([@CR262])Kuwait5.24.24.0Saeed et al. ([@CR207])EuropeCentral and Eastern Europe1.6UNEP ([@CR263])Croatia1.31.02.00.7Frkovic et al. ([@CR90])Denmark5.1Shen et al. ([@CR225])Denmark4.9Shen et al. ([@CR226])Finland2.8Shen et al. ([@CR225])Finland2.4Shen et al. ([@CR226])Finland and Denmark3.6Damgaard et al. ([@CR60])Germany14Schlaud et al. ([@CR219])Germany0.018--3.84Zietz et al. ([@CR295])Germany42Raab et al. ([@CR201])Great Britain4825Harris et al. ([@CR104])Netherlands50Albers et al. ([@CR7])Western Europe and other States2.5UNEP ([@CR263])The AmericasAntigua and Barbuda2.6UNEP ([@CR262])Brazil23Paumgartten et al. ([@CR190])Canada111.1Newsome and Ryan ([@CR171])Canada9.88.5Newsome et al. ([@CR172])Canada30Dewailly et al. ([@CR69])Chile5.0UNEP ([@CR262])Group of Latin America and Caribbean countries4.9UNEP ([@CR263])Mexico30--50Elvia et al. ([@CR79])Mexico280300290Rodas-Ortiz et al. ([@CR204])Nicaragua183.0Romero et al. ([@CR206])Uruguay4.9UNEP ([@CR262])When concentrations from more than one sampling site in the same country and study have been reported, the concentrations are given as two values separated by a semicolon ";" (two concentrations) or a dash "--" (for more than two concentrations)^a^Recalculated from fresh weight, assuming 4 % fat contentTable 10Concentrations (ng/g fat) of pentachlorobenzene (PCBz), toxaphene, and mirex, in mothers' milk, as reported in studies from around the world, 1995--2011, are presentedRegionCountryPCBz∑ToxapheneMirexReferenceMeanMedianGeo. meanMeanMedianMeanMedianGeo. meanAfricaNigeria4.1UNEP ([@CR262])Asia and the Pacific regionAustralia0.21Harden et al. ([@CR103])Australia0.18Mueller et al. ([@CR165])China2.4Zhou et al. ([@CR294])Hong Kong and South China0.8Hedley et al. ([@CR106])Korea0.8UNEP ([@CR262])EuropeDenmark0.360.23Shen et al. ([@CR225])Denmark0.320.21Shen et al. ([@CR226])Finland0.270.31Shen et al. ([@CR225])Finland0.250.26Shen et al. ([@CR226])Finland and Denmark0.280.22Damgaard et al. ([@CR60])Germany16Skopp et al. ([@CR230])NorwayPolder et al. ([@CR196])Russia10; 2010; 190.5; 0.80.5; 0.7Polder et al. ([@CR195])The AmericasAntigua and Barbuda1.3UNEP ([@CR262])Canada14Dewailly et al. ([@CR69])Canada3.0Fitzgerald et al. ([@CR87])Canada1.00.9168562.31.8Newsome and Ryan ([@CR171])Canada1.5^a^1.2^a^1.9^a^1.6^a^Newsome et al. ([@CR172])Mexico200Rodas-Ortiz et al. ([@CR204])Uruguay9.8UNEP ([@CR262])USA1.0--5.8Madden and Makarewicz ([@CR158])USA1.4Fitzgerald et al. ([@CR87])USA2.4Greizerstein et al. ([@CR99])USA4.8Kostyniak et al. ([@CR135])When concentrations from more than one sampling site in the same country and study have been reported, the concentrations are given as two values separated by a semicolon ";" (two concentrations)^a^Recalculated from fresh weight, assuming 4 % fat contentTable 11Concentrations (ng/g fat) of HBCDD and PBB, in mothers' milk, as reported in studies from around the world, 1995--2011, are presentedRegionCountryα-HBCDDβ-HBCDDγ-HBCDD∑HBCDD∑PBBReferenceMeanMedianMeanMedianMeanMedianMeanMedianMeanAfricaGhana0.29--0.790.23--0.620.0100.30--0.800.27--0.62Asante et al. ([@CR13])South Africa0.550.34Darnerud et al. ([@CR65])AsiaChina0.33--2.80.460.33--2.8Shi et al. ([@CR227])Japan1.41.4Kakimoto et al. ([@CR123])Philippines0.58; 0.720.50; 0.670.052; 0.180.043; 0.120.14; 0.480.13; 0.230.81; 1.00.52; 0.89Malarvannan et al. ([@CR159])Vietnam0.33; 0.380.33; 0.38Tue et al. ([@CR259])EuropeDenmark0.26Shen et al. ([@CR226])Finland0.17Shen et al. ([@CR226])Norway1.70.86Thomsen et al. ([@CR252])Russia0.47; 0.710.45; 062Polder et al. ([@CR195])Spain144.440234727Eljarrat et al. ([@CR78])Sweden0.450.30Aune et al. ([@CR22])Sweden0.63^a^; 0.80^a^0.58^a^Bergman et al. ([@CR29])Sweden0.39Fängström et al. ([@CR85])Sweden0.3--0.4Glynn et al. ([@CR97])Sweden0.420.35Lignell et al. ([@CR147])UK4.93.20.320.300.490.506.03.8Abdallah and Harrad ([@CR2])When concentrations from more than one sampling site in the same country and study have been reported, the concentrations are given as two values separated by a semicolon ";" (two concentrations) or a dash "--" (for more than two concentrations)^a^Quantified using BDE-139 as surrogate standardTable 12PFOS concentrations in mothers' milk, expressed in picograms per milliliter of milk as reported in studies from around the world, 1995--2011, are presentedRegionCountryMean (pg/mL)Median (pg/mL)ReferenceAsia and the PacificCambodia6740Tao et al. ([@CR248])China6--140Liu et al. ([@CR154])China120100So et al. ([@CR232])India4639Tao et al. ([@CR248])Indonesia8467Tao et al. ([@CR248])Japan230200Tao et al. ([@CR248])Malaysia120110Tao et al. ([@CR248])Philippines98100Tao et al. ([@CR248])South Korea61Kim et al. ([@CR131])Vietnam7659Tao et al. ([@CR248])EuropeGermany120; 130110; 120Volkel et al. ([@CR271])Germany40Fromme et al. ([@CR91])Hungary310330Volkel et al. ([@CR271])Spain120110Kärrman et al. ([@CR127])Spain120Llorca et al. ([@CR155])Sweden120--260170Kärrman et al. ([@CR126])Sweden120Kärrman et al. ([@CR125])Sweden75Sundström et al. ([@CR245])The AmericasUSA130110Tao et al. ([@CR248])When concentrations from more than one sampling site in the same country and study have been reported, the concentrations are given as two values separated by a semicolon ";" (two concentrations) or a dash "--" (for more than two concentrations)Table 13Concentrations (ng/g fat) of endosulfan, in mothers' milk, as reported in studies from around the world, 1995--2011, are presentedRegionCountryα-Endosulfanβ-Endosulfan∑EndosulfanEndosulfan sulfateReferenceMeanMedianMeanMedianMeanMedianMeanMedianAfricaEgypt4.8Saleh et al. ([@CR209])AsiaIndia9100^a,\ b^Sanghi et al. ([@CR210])Turkey50^a^950^a^1000^a^Cok et al. ([@CR55])EuropeSpain17^a^22^a^270^a^180^a^280^a^200^a^150^a^120^a^Cerrillo et al. ([@CR41])Denmark7.4Shen et al. ([@CR225])Denmark7.4Shen et al. ([@CR226])Denmark and Finland6.8Damgaard et al. ([@CR60])Finland7.3Shen et al. ([@CR225])Finland6.4Shen et al. ([@CR226])The AmericasMexico280Rodas-Ortiz et al. ([@CR204])When concentrations from more than one sampling site in the same country and study have been reported, the concentrations are given as two values separated by a semicolon ";" (two concentrations) or a dash "--" (for more than two concentrations)^a^Recalculated from fresh weight, assuming 4 % fat content^b^Nonspecified isomer/sOne reported concentration from one sample location is represented by a single value, e.g., "5."Two reported concentrations from one location are represented by two values separated by a semicolon, e.g., "3; 5."Three or more reported concentrations from one sample location are represented by giving the range, e.g., "3--5."If a study reports data from more than one sampling location, all are included, e.g., by presenting, "Sweden 5" and "Norway 4."In the case of a time series, i.e., more than one sample from one location, only the most recent value is included in the summary table.A "sum value" is only given if more than one of the components of the "sum value" are reported.If "sum values" are reported, the reported value is used. If not reported, the sum is calculated if possible.If data from the same samples are presented in several studies, only the latest study is included in the table.Three-letter country codes according to ISO 3166-1 alpha-3 are used in the figures, herein.

Spatial distribution diagrams {#Sec7}
-----------------------------

If mean or median values are given for different sampling locations within the same country or subgroups (e.g., age, primiparae versus multiparae), a weighted mean or median value is calculated based on the number of individuals in each group: for example, reported mean concentrations of 2, 3, and 5 ng/g fat of BDE-47, based on 10, 10, and 20 samples (total of 40 samples) from cities X, Y and Z in Sweden, respectively. The weighted mean value for study A will thus be a bar at 3.75 ng/g fat example given below.$$\documentclass[12pt]{minimal}
                \usepackage{amsmath}
                \usepackage{wasysym} 
                \usepackage{amsfonts} 
                \usepackage{amssymb} 
                \usepackage{amsbsy}
                \usepackage{mathrsfs}
                \usepackage{upgreek}
                \setlength{\oddsidemargin}{-69pt}
                \begin{document}$$ \frac{2\mathrm{ng}/\mathrm{g}\times 10}{40}+\frac{3\mathrm{ng}/\mathrm{g}\times 10}{40}+\frac{5\mathrm{ng}/\mathrm{g}\times 20}{40}=3.75\mathrm{ng}/\mathrm{g} $$\end{document}$$

Equation 1. Example of how the weighted means were calculated.

In the spatial distribution diagrams, e.g., Fig. [3](#Fig3){ref-type="fig"}, the studies are sorted by rising concentrations within each region.

Methods applied for statistical reports {#Sec8}
---------------------------------------

To test for significant log-linear trends, log-linear regression analyses were performed for the entire investigated time period and for the most recent 10 years using the annual arithmetic mean values. In cases where the regression line had a poor fit, a 3-point running mean smoother was checked for statistical significance in comparison with the regression through an ANOVA (Nicholson et al. [@CR176]). Potential outliers in the temporal trends were detected using a method described by Hoaglin and Welsch ([@CR107]). The suspected outliers are merely indicated in the figures and were included in the statistical calculations. Values below level of quantification (LOQ) were replaced by LOQ/2 prior to the statistical analyses. Power analysis was also carried out. The power was fixed to 80 % and the minimum possible trend to be detected during a monitoring period of 10 years at a significant level of 5 % was estimated. A significance level of 5 % was used for all tests.

Results and discussion {#Sec9}
======================

A total of 253 scientific articles on POPs in mothers' milk were identified on the basis of the applied methodology (cf. above). Several of the articles included data on more than one of the POPs. The diagram (Fig. [1](#Fig1){ref-type="fig"}) visualizes the number of reported concentrations of the corresponding POP that were available for this review. The results are presented in this review in descending order, starting from the POPs that are most well researched in relation to occurrence and concentrations in mothers' milk, worldwide, i.e., going from DDT to SCCP and chlordecone (Fig. [1](#Fig1){ref-type="fig"}).Fig. 1Number of reported observations (total 744) in 253 scientific papers of the legacy POPs in mothers' milk, from 1995 to 2011, subdivided on the POPs reported herein and presented in order of abundance of studies. Eighty percent of all studies are linked to seven of the POPs, DDT---chlordane. Note that a scientific paper may include observations of more than POP

Looking into the distribution of the scientific articles published on POPs in mothers' milk in the chosen time period, it is clear that most of the studies originate from China, Japan, North America, and Western Europe (Fig. [2](#Fig2){ref-type="fig"}). However, publications are scattered throughout the globe making a spatial trend review possible. The results of the spatial distribution and concentrations of POPs are presented under the sections "[DDT and DDT-related compounds](#Sec10){ref-type="sec"}" to "[SCCPs](#Sec55){ref-type="sec"}," including tables and figures when applicable. Temporal trend data on POPs in mothers' milk are scarce but available data are reported herein under the sections "[DDT and DDT related compounds](#Sec58){ref-type="sec"}" to "[PFOS](#Sec66){ref-type="sec"}." Some novel data are included for recent exposure assessments performed on mothers' milk from Sweden.Fig. 2Global distribution of exposure assessment studies of POPs in mothers' milk, up to year 2011. The *circles* are placed at the site of the capital city for each country, and the sizes of the *circles* visualize the abundance of studies from the countries on which this review is built. *Black circle* = 1 study, *green circle* = 2--5 studies, *blue circle* = 6--10 studies, *red circle* = 11--15 studies, and *pink circle* \>15 studies

All concentration data given in Tables [2](#Tab2){ref-type="table"}, [3](#Tab3){ref-type="table"}, [4](#Tab4){ref-type="table"}, [5](#Tab5){ref-type="table"}, [6](#Tab6){ref-type="table"}, [7](#Tab7){ref-type="table"}, [8](#Tab8){ref-type="table"}, [9](#Tab9){ref-type="table"}, [10](#Tab10){ref-type="table"}, [11](#Tab11){ref-type="table"}, [12](#Tab12){ref-type="table"}, and [13](#Tab13){ref-type="table"} are presented on a weight basis (ng or pg) per gram extracted fat, with the exception of perfluorooctane sulfonate (PFOS) which is presented in pg/mL.

It is of importance to consider that a reported concentration might not be generally applicable to a country as a whole, for instance, samples might originate from a farming area where pesticides have been in use. This could be more important to consider for countries with large diversity, either geographically and/or cultural, i.e., rural versus urban life styles. In smaller, more homogenous countries such as Sweden, POP concentrations have been found to be quite uniform, independent of geographical distribution (Glynn et al. [@CR97]).

DDT and DDT-related compounds {#Sec10}
-----------------------------

A very large total number of reports are dealing with DDT and related compounds in mothers' milk. Related compounds are 2,4′-DDT and the transformation products 4,4′-DDE, 4,4′-DDD, 2,4′-DDE, and 2,4′-DDD. The data shown in Table [2](#Tab2){ref-type="table"} refer only to the three individual compounds 4,4′-DDT, 4,4′-DDE, and 4,4′-DDD as well as ∑DDT. However, the ∑DDT may consist of some very different sums, sometimes including only the three main 4,4′-substituted DDTs mentioned but occasionally also including 2,4′-substituted DDTs. This makes the sum data less reliable for comparisons. However, we have still chosen to include sum data to visualize the larger data set, but avoiding the confusion with further differentiated data. Concentration data on 4,4′-DDT, 4,4′-DDE, and 4,4′-DDD are presented in detail in Table [2](#Tab2){ref-type="table"}, subsectioned into four geographically large areas, i.e., Africa; Asia, Australia, and the Pacific region; Europe; and The Americas. Some of the results on DDT and related compounds in mothers' milk are highlighted below.

Table [2](#Tab2){ref-type="table"} includes calculated ratio values of 4,4′-DDT/4,4′-DDE based on reported mean or median concentrations of the two compounds and gives an indication for recent discharges of DDT (with ratio values of 0.5 and above) or more historical use (ratios below 0.2) of this pesticide. Figure [3](#Fig3){ref-type="fig"} displays the 4,4′-DDT and 4,4′-DDE concentrations as reported throughout the world.Fig. 3The sum of p,p-DDE and p,p-DDT reported worldwide is given in the figure, where contribution p,p-DDE is represented in *dark blue* and the contribution p,p-DDT is represented in *orange*

### Africa {#Sec11}

Concentrations of 4,4′-DDE are the highest among the three individual DDT compounds reported in Table [2](#Tab2){ref-type="table"}, although the 4,4′-DDT/4,4′-DDE ratio indicates similar levels between the two major constituents in mothers' milk. The highest concentrations of 4,4′-DDT and 4,4′-DDE are reported from Zimbabwe (Chikuni et al. [@CR46]) and South Africa (Okonkwo et al. [@CR185]; Sereda et al. [@CR223]). Still, a few studies indicate low concentrations of DDTs in mothers' milk. It is particularly clear that African mothers have high concentrations of 4,4′-DDT compared to most other samples from other regions. This is of course implying present or recent use of DDT for spraying, potentially indoors (Channa et al. [@CR43]).

### Asia, Australia, and the Pacific region {#Sec12}

Reports from Asia, Australia, and the Pacific Region indicate that certain mothers have been highly exposed to both 4,4′-DDT and 4,4′-DDE (Nair et al. [@CR168]; Nasir et al. [@CR170]; Stuetz et al. [@CR237]; Wong et al. [@CR284]), while overall levels are above the common European concentrations, but below the concentrations reported for milk from African mothers (Table [2](#Tab2){ref-type="table"} and Fig. [3](#Fig3){ref-type="fig"}). The data indicate primarily old releases of DDT based on the low 4,4′-DDT/4,4′-DDE ratio, although there are exceptions (e.g., Nair et al. [@CR168]; Nasir et al. [@CR170]; Stuetz et al. [@CR237]; Wong et al. [@CR284]). Accordingly, direct exposure to DDT cannot be excluded.

### Europe {#Sec13}

The majority of studies on DDT in mothers' milk are originating from Europe. The levels are in the lowest end (e.g., 20--250 ng/g fat of 4,4′-DDE) of all studies reviewed except for studies on DDTs in milk from the Eastern part of Europe, 250--2800 ng/g fat, as shown in Table [2](#Tab2){ref-type="table"}. The higher concentrations in Eastern Europe is also followed by higher 4,4′-DDT/4,4′-DDE ratios indicating more recent use or unintentional release of DDT. However, the ratio is generally low indicating successful elimination of this POP from use in the society. The DDT and related compounds still present in mothers' milk are a mirror of intake via food. Some high exposure levels to DDT among Eastern European citizens, as determined by analysis of blood, are supporting the higher levels in mothers' milk from countries in this part of Europe (Hovander et al. [@CR110]).

### The Americas {#Sec14}

Low concentrations of DDTs are reported from Canada and the USA, while Mexico in Central America (Table [2](#Tab2){ref-type="table"}) reported levels that are similarly high as in Africa and some Asian countries. It is notable that in the countries from which the mothers' milk contain the highest concentrations of DDTs, there is a more recent input of DDT (Fig. [3](#Fig3){ref-type="fig"}), which is confirmed by higher 4,4′-DDT/4,4′-DDE ratios, 0.12--0.4 (Table [2](#Tab2){ref-type="table"}). A Brazilian study is reporting the highest ratio among all studies reviewed, i.e., 12 (Azeredo et al. [@CR23]), indicating the present use of DDT. However, the actual concentration of ∑DDTs is lower than many other studies.

PCBs {#Sec15}
----

Polychlorinated biphenyls (PCBs) reported as CB-153, sum of the six indicator CBs (CB-28, CB-52, CB-101, CB-138, CB-153, and CB-180, only if the concentrations of all six were reported), or the estimated total sum of PCB (∑PCB, the method of estimating the sum may vary between studies) in all 116 studies were tabulated (Table [3](#Tab3){ref-type="table"}). Dioxin-like PCBs are not reported here but instead discussed together with the dioxins and furans ("[PCDDs, PCDFs, and DL-PCBs](#Sec30){ref-type="sec"}"). Since PCBs are showing decreasing trends after the bans came into effect, studies from different time periods (1995--2011) may not be altogether comparable (Fig. [4](#Fig4){ref-type="fig"}).Fig. 4**a**--**c** Graphical presentation of PCB concentrations in mothers' milk from countries worldwide

### Africa {#Sec16}

Five studies of PCBs from Africa were found in the database search. CB-153 ranges from approximately 2 to 120 ng/g fat in South Africa (Darnerud et al. [@CR65]) and Tunisia (Ennaceur et al. [@CR81]), respectively. The reported ∑PCB ranges from about 3 to 750 ng/g fat in Zimbabwe (Chikuni et al. [@CR46]) and Tunisia (Ennaceur et al. [@CR81]), respectively.

### Asia, Australia, and the Pacific region {#Sec17}

No less than 36 studies were found from this region and the majority report estimated ∑PCB. The lowest concentrations are from China (Kunisue et al. [@CR141]; Xing et al. [@CR285]), India (Devanathan et al. [@CR67]), Indonesia (Sudaryanto et al. [@CR239]), and Cambodia (Kunisue et al. [@CR141]). Higher concentrations of ∑PCB were reported from Australia, 160--480 ng/g fat (Quinsey et al. [@CR200]); Japan, 120--200 ng/g fat (Kawashiro et al. [@CR128]; Kunisue et al. [@CR143]; Nagayama et al. [@CR166]; Nakamura et al. [@CR169]); Kazakhstan, 220--820 ng/g fat (Hooper et al. [@CR108]; Lutter et al. [@CR157]; She et al. [@CR224]); and Russia, 160--240 ng/g fat (Tsydenova et al. [@CR258]). The lowest concentrations of CB-153, 0.5 ng/g fat, were reported from China (Zhang et al. [@CR291]) and the highest in Iran, over 200 ng/g fat (Behrooz et al. [@CR27]).

### Europe {#Sec18}

Over 50 % of the included studies came from Europe. The lowest concentrations of CB-153 in Europe, lower than 50 ng/g fat, came from Belgium (Colles et al. [@CR56]), Italy (Ulaszewska et al. [@CR260]), Latvia (Bake et al. [@CR24]), Norway (Polder et al. [@CR196]), Poland (Jaraczewska et al. [@CR121]), and Sweden (Lignell et al. [@CR147]). The highest concentrations (more than 300 ng/g fat) were reported from the Czech Republic (Bencko et al. [@CR28]; Cerna et al. [@CR40]; Schoula et al. [@CR220]) and Slovak Republic (Petrik et al. [@CR191]). This is also true for the estimated ∑PCB, when reported. Concentrations \>1000 ng/g fat are reported from the Czech Republic (Bencko et al. [@CR28]; Cerna et al. [@CR40]; Schoula et al. [@CR220]), Germany (Schlaud et al. [@CR219]), and the Slovak Republic (Petrik et al. [@CR191]). Although the ban of PCB that was introduced stepwise during the 1970s and 1980s has led to significantly lowered concentrations in the environment, leakage due to inappropriate handling of waste material or from, e.g., building material, large capacitors, and hydraulic systems, still in use or stored at dumping sites, can still be expected and can thus cause elevated concentrations in mothers' milk from highly industrialized countries.

### The Americas {#Sec19}

The concentrations of CB-153 reported from most of the 14 studies from the Americas were fairly low to moderate, around or below 50 ng/g fat: Brazil (Paumgartten et al. [@CR190]), Canada (Dewailly et al. [@CR68]; Newsome et al. [@CR172]), and the USA (Fitzgerald et al. [@CR86]; Pan et al. [@CR187]). The highest concentration of CB-153, 110 ng/g fat (Rodas-Ortiz et al. [@CR204]), as well as of the estimated ∑PCB, 1500 ng/g fat (Rodas-Ortiz et al. [@CR204]), was reported from Mexico.

HCB and HCHs {#Sec20}
------------

Mothers' milk concentrations of hexachlorobenzene (HCB) and the three more common hexachlorocyclohexane (HCH) isomers, α-HCH, β-HCH, and γ-HCH, are presented in Table [4](#Tab4){ref-type="table"}, as well as the less commonly reported levels of δ-HCH. α-HCH, β-HCH, and γ-HCH represent the HCHs present in the "old" technical-grade HCH pesticide, while the commonly used pesticide, lindane, corresponds to γ-HCH. All the HCH isomers are related to pesticide use, while HCB has both a pesticide history and is also an abundant by-product from industrial activities and poorly controlled incineration/backyard burning. The pattern of HCH in the world is highly influenced by recent use of HCH as a pesticide. It is notable that the β-HCH isomer is the most abundant of the HCH isomers in mothers' milk even though this compound is related to the historical HCH pesticide use and not to lindane (γ-HCH). However, the half-life of γ-HCH is much shorter in humans and wildlife than the half-life of β-HCH, and the observations confirm the higher persistency and lower reactivity of the β-HCH isomer compared to the others.

The data for HCB and the HCHs are dominated by studies of mothers' milk from Asia and Europe (Table [4](#Tab4){ref-type="table"}) and are reported in 94 and 113 scientific reports worldwide, respectively (Figs. [5](#Fig5){ref-type="fig"} and [6](#Fig6){ref-type="fig"}).Fig. 5**a**--**c** Graphical presentation of HCB concentrations in mothers' milk from countries worldwideFig. 6**a**--**d** Graphical presentation of HCH concentrations in mothers' milk from countries worldwide. Note that "RUS, Asia" refers to samples from a location in the Asian part of the Russian Federation

### Africa {#Sec21}

Most reported HCB concentrations from African countries range from about 2 to 5 ng/g fat, on either mean or median basis. Somewhat higher levels are reported in Ghananese mothers' milk, 2.5--40 ng/g fat (Darko and Acquaah [@CR62]; Ntow [@CR181]; UNEP [@CR262]). The highest concentrations are reported from Tunisia, mean concentration of 0.4--290 ng/g fat (Ennaceur et al. [@CR80], [@CR81]).

In general, one could consider the ∑HCH levels in African mothers' milk to be on the lower end on a global scale and comparable to concentrations reported from the Americas. There are quite few studies from Africa reporting levels of ∑HCH in mothers' milk. Most of the studies report mean concentrations of approximately 10--100 ng/g fat (Table [4](#Tab4){ref-type="table"}), the exceptions being one study from Ghana (Saleh et al. [@CR209]) and one study from Libya (Elafi et al. [@CR77]), reporting concentrations of 210 and 500 ng/g fat, respectively.

### Asia, Australia, and the Pacific region {#Sec22}

A few countries have reported HCB mean concentrations below 10 ng/g fat: Cambodia (Kunisue et al. [@CR141]), India (Devanathan et al. [@CR67]), Korea (UNEP [@CR262]), and the Philippines (Malarvannan et al. [@CR159]). However, the majority of countries have reported mean values in the range 10--100 ng/g fat (Table [4](#Tab4){ref-type="table"}). In the higher end of reported HCB, concentrations from the region include Australian levels between 370 and 460 ng/g fat (Behrooz et al. [@CR27]; Quinsey et al. [@CR200]), with levels up to 1500 ng/g fat, as well as Kazakhstan (Hooper et al. [@CR108]) and Thailand (Stuetz et al. [@CR237]), reporting concentrations above 100 ng/g fat (Table [4](#Tab4){ref-type="table"}).

The reported levels of HCHs, both individual isomers as well as ∑HCH, are the highest in Asia, Australia, and the Pacific region, compared to the rest of the world, although there are a few studies reporting comparatively low mean concentrations, i.e., below 10 ng/g fat: Cambodia (Kunisue et al. [@CR141]), Kuwait (Saeed et al. [@CR207]), the Philippines (Malarvannan et al. [@CR159]), and Taiwan (Chao et al. [@CR45]) but also studies from Japan (Nagayama et al. [@CR166]) and Australia (Khanjani and Sim [@CR130]; Kunisue et al. [@CR141]). On the contrary, other studies from Japan and Australia report higher concentrations (Table [4](#Tab4){ref-type="table"}). The majority of studies from Asia, Australia, and the Pacific region report ∑HCH concentrations in the range of hundreds of nanogram per gram fat, but a large number report concentrations in the range of thousands of nanogram per gram fat (Table [4](#Tab4){ref-type="table"}). In India, there is a high HCH contamination according to the mothers' milk concentrations, which range from 120 to 22,000 ng/g fat ∑HCH, with several studies reporting values of thousands of nanogram per gram fat (Table [4](#Tab4){ref-type="table"}). The highest concentrations of the HCH isomers in mothers' milk have been reported from India with means of 1800, 16,000, 1300, and 2300 ng/g fat for α-HCH, β-HCH, γ-HCH, and δ-HCH, respectively (Siddiqui et al. [@CR228]).

### Europe {#Sec23}

In general, the HCB concentration in European mothers' milk is higher than the rest of the world, although the most extreme values of HCB in mothers' milk are not from Europe. Only two European countries, Croatia (Frkovic et al. [@CR90]) and Finland (Shen et al. [@CR225]), report mean HCB concentrations below 10 ng/g fat, while several Croatian studies report median concentrations above 10 ng/g fat (Krauthacker et al. [@CR138], [@CR139]; Romanic and Krauthacker [@CR205]). The majority of the HCB concentrations reported from European countries are in the range of 10--100 ng/g fat, reported on either mean and median basis (Table [4](#Tab4){ref-type="table"}). In Europe, it is primarily the Eastern countries that report highly elevated HCB levels in the analyzed mothers' milk, with the highest levels from the Czech Republic, median values up to 370 ng/g fat (Cajka and Hajslova [@CR36]; Cerna et al. [@CR40]). However, high levels are also reported in Spanish mothers' milk with medians of 630 and 910 ng/g fat (Ribas-Fito et al. [@CR202]).

The HCH concentrations in mothers' milk from European mothers in general show significantly lower concentrations than milk from Asia, Australia, and the Pacific regions, but higher than concentrations reported from Africa and the Americas. The reported European levels of ∑HCH are for the most part homogenous, and the majority of mean and/or median concentrations are in the range 10--100 ng/g fat. However, there are a number of studies from Denmark (Shen et al. [@CR225]), Finland (Shen et al. [@CR225]), Romania (Covaci et al. [@CR57]), and Russia (Polder et al. [@CR194]; Tsydenova et al. [@CR258]) that report ∑HCH concentrations of several hundreds of nanogram per gram fat (Table [4](#Tab4){ref-type="table"}). The highest reported mean concentration is 1000 ng/g fat, in a study from Russia (Tsydenova et al. [@CR258]).

### The Americas {#Sec24}

Overall, the HCB contamination seems to be lower in the Americas than any of the other regions with a higher portion of studies below 10 ng/g fat and no study reporting concentrations above 100 ng/g fat (Table [4](#Tab4){ref-type="table"}). Antigua and Barbuda (UNEP [@CR262]) along with a number of studies from the USA report levels below 10 ng/g fat. However, two studies report a mean concentration of 15 ng/g fat (Greizerstein et al. [@CR99]) and a median concentration of 14 ng/g fat (Fitzgerald et al. [@CR87]). The two highest mean concentrations of HCB were reported in studies of Mexican mothers' milk, reaching 92 and 53 ng/g fat (Rodas-Ortiz et al. [@CR204]; Waliszewski et al. [@CR274]), and the third highest was reported from Canada, 43 ng/g fat (Newsome and Ryan [@CR171]).

In the Americas, the ∑HCH concentrations are similar to the concentrations in Europe, albeit there are fewer reported observations. The two lowest concentrations are from Antigua and Barbuda (UNEP [@CR262]) and Nicaragua (Romero et al. [@CR206]), 5 and 7 ng/g fat, respectively. The majority of studies report values in the lower end of the range 10--100 ng/g (Table [4](#Tab4){ref-type="table"}), although exceptions to this are reported concentrations in the range of hundreds of nanogram per gram from Brazil (Paumgartten et al. [@CR190]) and Mexico (Elvia et al. [@CR79]; Rodas-Ortiz et al. [@CR204]; Waliszewski et al. [@CR274]), with the highest mean concentration reported in mothers' milk from Mexico, at 750 ng/g fat.

Chlordane {#Sec25}
---------

Chlordane concentrations reported as oxychlordane, α-chlordane, γ-chlordane, and ∑chlordanes from 63 studies, were selected and tabulated (Table [5](#Tab5){ref-type="table"}).

### Africa {#Sec26}

Only ∑chlordanes from four countries on the African continent were reported. The highest concentrations were from Senegal, with a mean concentration of 11.7 ng/g fat (UNEP [@CR262]).

### Asia, Australia, and the Pacific region {#Sec27}

Concentrations of oxychlordane vary greatly between countries, mostly between 0.5 and 10 ng/g fat. Extreme concentrations (140 and 150 ng/g fat) are reported from one Australian study (Quinsey et al. [@CR200]), whereas the other studies from Australia report concentrations below 20 ng/g fat. Banned in most countries in 1997, chlordane was still allowed to be used as a termiticide in the Northern Territory (Australia) (UNEP Chemicals). Concentrations of α- and γ-chlordane are only reported from a few countries, whereof extreme concentrations are reported from Jordan 460 and 590 ng/g fat, respectively (Nasir et al. [@CR170]). The highest concentrations of ∑chlordanes were reported from Japan (Konishi et al. [@CR134]; Kunisue et al. [@CR143]), while studies from the rest of the countries in the region report concentrations generally below 10 ng/g fat.

### Europe {#Sec28}

Fourteen studies from Europe report mean concentrations of oxychlordane, most of them close to or below 5 ng/g fat, and the reported median concentrations are in general of the same magnitude. The highest values of oxychlordane in Europe are reported from Ukraine (16--22 ng/g fat) (Gladen et al. [@CR93], [@CR94]). Only very few countries reported ∑chlordanes, whereof the highest values, 10--60 ng/g fat, are reported from Russia (Polder et al. [@CR194], [@CR195]; Tsydenova et al. [@CR258]). One study reports concentrations below 4 ng/g fat from Western, Central, and Eastern Europe (UNEP [@CR263]).

### The Americas {#Sec29}

A few studies from the American continent in general show higher concentration of oxychlordane (Johnson-Restrepo et al. [@CR122]; Newsome et al. [@CR172]; Newsome and Ryan [@CR171]) compared to Europe. The highest concentrations are between 40 and 60 ng/g fat from Canada (Newsome and Ryan [@CR171]) and Mexico (Elvia et al. [@CR79]). A few studies reporting concentrations of α- and γ-chlordane give values below 3 ng/g fat, except extreme concentrations reported from Mexico, 260 and 930 ng/g fat, respectively (Rodas-Ortiz et al. [@CR204]).

PCDDs, PCDFs, and DL-PCBs {#Sec30}
-------------------------

The polychlorinated dibenzo-*p*-dioxin/polychlorinated dibenzofuran (PCDD/PCDF) and dioxin-like PCB (DL-PCB) concentrations are reported as toxic equivalents (TEQs) based on WHO TEF values from 1998 (Van den Berg et al. [@CR266]) and 2005 (Van den Berg et al. [@CR267]). Total mean TEQ~2005~ varies between 3.1 and 7.2 pg TEQs/g fat for the three countries studied in Africa (UNEP [@CR262]). The use of mean or median concentrations applying TEF~1998~ or TEF~2005~ results in four different total TEQs. Still, some spatial comparisons are possible. Both Brazil (Paumgartten et al. [@CR190]) and Chile (UNEP [@CR262]) show higher total TEQ~2005~ than the African countries. When comparing these total TEQ~2005~ concentrations with mothers' milk from Europe (Table [6](#Tab6){ref-type="table"}), we confirm generally higher TEQs from Europe than the countries mentioned in Africa and South America. Further comparisons are not made here due to the extensive complications in doing so.

PBDEs {#Sec31}
-----

Concentrations of PBDEs, BDE-47, BDE-209, and ∑PBDE data are summarized in Table [7](#Tab7){ref-type="table"} and Figs. [7](#Fig7){ref-type="fig"} and [8](#Fig8){ref-type="fig"}.Fig. 7Graphical presentation of BDE-47 concentrations in mothers' milk from countries worldwideFig. 8Graphical presentation of BDE-209 concentrations in mothers' milk from countries worldwide.

### Africa {#Sec32}

Only two studies of PBDEs in mothers' milk from Africa were identified, and both studies confirm the occurrence of BDE-47 in mothers' milk at mean or median concentrations below 2 ng/g fat (Asante et al. [@CR13]; Darnerud et al. [@CR65]). BDE-209 was only reported in one study from Ghana (Asante et al. [@CR13]).

### Asia and the Pacific region {#Sec33}

The concentrations of BDE-47 are rather uniform and low (below 2 ng/g fat) in mothers' milk in Asia and the Pacific region, even though a very large geographical area is covered. One study from Japan reports the highest level of BDE-47 outside the USA with a mean concentration of 19 ng/g fat (Akutsu and Hori [@CR3]). From the Philippines, a study reports somewhat elevated levels, mean concentrations of 1.2 and 4.9 ng/g fat (13). Both low and high BDE-47 concentrations have been determined in samples from Turkey, with mean concentrations reaching 6.0 ng/g fat (Erdogrul et al. [@CR82]; Ozcan et al. [@CR186]).

BDE-209 was reported in 6 out of 16 studies with similar levels (\<1 ng/g fat) independent of the study (cf. Table [7](#Tab7){ref-type="table"}). The highest BDE-209 concentrations are reported in mothers' milk from the Philippines and Vietnam with levels of around 2 ng/g fat (Malarvannan et al. [@CR159]; Tue et al. [@CR259]).

The reported ∑PBDEs in Asian mothers' milk confirm the observations of BDE-47 concentrations, with the highest concentrations from the Philippines, mean concentrations of 5--10 ng/g fat (Malarvannan et al. [@CR159]; Sudaryanto et al. [@CR241]), as well as from Japan and Turkey with mean concentrations of 31 and 67 ng/g fat, respectively (Akutsu and Hori [@CR3]; Ozcan et al. [@CR186]). These concentrations are comparable with the levels reported in mothers' milk from the USA.

### Europe {#Sec34}

In general, the concentrations of BDE-47 in mothers' milk in Europe (approximately 1--2 ng/g fat) are higher compared to the levels in Asia and the Pacific region and Africa but lower than in the Americas. The lowest levels of BDE-47 in Europe are reported in samples from the Czech Republic, Germany, Italy, and Russia, with mean concentrations below 1 ng/g fat (Alivernini et al. [@CR9]; Kazda et al. [@CR129]; Polder et al. [@CR195]; Raab et al. [@CR201]). The highest levels are reported in mothers' milk from the UK with median concentration of 2.7 ng/g fat (Kalantzi et al. [@CR124]), and the remaining results from Europe are in between the mentioned BDE-47 concentrations (Table [7](#Tab7){ref-type="table"}). Hence, the differences in the levels are rather small.

As few as 7 out of 25 of the European mothers' milk samples report BDE-209, with the highest concentrations in samples from France, 1.5 ng/g fat (Antignac et al. [@CR12]; Athanasiadou and Bergman [@CR15]). Since BDE-209 has a short half-life in humans, 14 days (Thuresson et al. [@CR253]), the differences in concentrations of this PBDE congener vary greatly. Consequently, exposure levels of BDE-209 and nona-BDEs become uncertain when seen over time.

In Europe, the ∑PBDE concentrations are in general 3--4 ng/g fat, with a few exceptions (Table [7](#Tab7){ref-type="table"}). The highest ∑PBDE concentrations are reported in mothers' milk from the UK, with median levels of 6.3 ng/g fat, which is still three to five times lower than levels reported from the USA.

### The Americas {#Sec35}

Only studies from the USA could be found that report levels of PBDEs from the Americas and that met the criteria set for this review.

In general, the reported levels of BDE-47 are much higher in the mothers' milk samples from the USA compared to the rest of the world. The concentrations are rather uniform, with mean values at 35--40 ng/g fat (Johnson-Restrepo et al. [@CR122]; Schecter et al. [@CR215], [@CR216], [@CR217]), but with levels reaching as high as 73 ng/g fat (Park et al. [@CR189]). Also, the levels of BDE-209 are higher in the USA than the rest of the world (Table [7](#Tab7){ref-type="table"}), which is indicating a higher prevalence of deca-BDE exposure.

Also, the concentrations of ∑PBDEs in the samples from the USA are overall similar, with means of 66--76 ng/g fat, and one median value of 51, reported in four different studies (Johnson-Restrepo et al. [@CR122]; Schecter et al. [@CR215], [@CR216], [@CR217]). However, one study reports a mean concentration as high as 130 ng/g fat (Park et al. [@CR189]).

The results clearly show that US mothers' milk contains the highest concentrations of PBDEs. This is in line with any other exposure study from the USA, showing mothers and other individuals being subjected to environmental exposures of PBDEs that are the highest in the world.

Heptachlor {#Sec36}
----------

Heptachlor concentrations reported as *cis*-HCL-epoxide, HCL-epoxide, and heptachlor from 49 studies were selected and tabulated (Table [8](#Tab8){ref-type="table"}). Concentrations of *cis*-HCL-epoxide are only reported from one or a few countries from each continent/region, and they range between 0.7 ng/g fat in China (Hedley et al. [@CR106]) and 8 ng/g fat in Brazil (Paumgartten et al. [@CR190]).

### Africa {#Sec37}

Heptachlor was only reported from four regions of the African continent with concentrations ranging between 0.9 and 2.25 ng/g fat (UNEP [@CR262], [@CR263]).

### Asia, Australia, and the Pacific region {#Sec38}

Fifteen studies report concentrations of HCL-epoxide. Most of these report concentrations below 10 ng/g fat, but higher concentrations are reported from Australia, 53 and 78 ng/g fat (Quinsey et al. [@CR200]); Jordan, 190 ng/g fat (Nasir et al. [@CR170]); Thailand, 60 ng/g fat (Stuetz et al. [@CR237]); and Turkey, 61 ng/g fat (Cok et al. [@CR53]). The highest reported concentration of heptachlor is from Jordan at 500 ng/g fat (Nasir et al. [@CR170]).

### Europe {#Sec39}

Concentrations of HCL-epoxide reported from Europe are in most cases below or close to 3 ng/g fat, although higher concentrations are reported from Ukraine, 16--22 ng/g fat (Gladen et al. [@CR93], [@CR94]), and the Netherlands, 30 ng/g fat (Albers et al. [@CR7]).

### The Americas {#Sec40}

Concentrations of HCL-epoxide and heptachlor from the Americas are reported as less than 4 ng/g fat except for Mexico, 160 and 580 ng/g fat, respectively (Rodas-Ortiz et al. [@CR204]).

Dieldrin, endrin, and aldrin {#Sec41}
----------------------------

The OCPs discussed herein were regulated at an early stage in many countries. Despite of this, rather high concentrations of dieldrin are reported (Table [9](#Tab9){ref-type="table"}).

### Africa {#Sec42}

No studies were retrieved that report aldrin and/or endrin in mothers' milk from any African nation. Dieldrin was reported in seven studies, three of which were part of the UNEP screening program with the lowest levels in mothers' milk from Ghana, Nigeria, and Senegal, with mean concentrations of 1.3--4.1 ng/g fat (UNEP [@CR262]). However, some reports indicate levels of up to 25--120 ng/g fat (Ennaceur et al. [@CR80], [@CR81]; Ntow et al. [@CR182]).

### Asia and the Pacific region {#Sec43}

Although only few studies report aldrin concentrations in mothers' milk, the variation is great. The most comprehensive study originates from Australia showing a large national spatial distribution in a range 0.01--0.68 ng/g fat (Harden et al. [@CR103]). Somewhat higher levels of aldrin are found in Kuwait and the highest concentration are from India and Jordan with mean concentrations up to 860 ng/g fat (Nasir et al. [@CR170]; Siddiqui et al. [@CR228]).

Dieldrin is more frequently reported in mothers' milk than aldrin and endrin and at rather high concentrations (Table [9](#Tab9){ref-type="table"}). The levels of dieldrin are rarely above 100 ng/g fat, with the exceptions of one study from Jordan, which reports a mean concentration of 1400 ng/g fat (Nasir et al. [@CR170]), and one study from China, 9300--10,000 ng/g fat (Wang et al. [@CR278]). Only two studies have been retrieved reporting on endrin in mothers' milk, one from Jordan and one from Kuwait (Nasir et al. [@CR170]; Saeed et al. [@CR207]).

### Europe {#Sec44}

A study from Croatia reports aldrin and endrin in their samples, with mean concentrations of 1.3 and 2.0 ng/g fat, respectively (Frkovic et al. [@CR90]). Again, the occurrence of dieldrin in mothers' milk is frequently reported from European countries in low concentrations, for example in samples from Germany and Croatia, with mean concentrations below 3.8 ng/g fat (Frkovic et al. [@CR90]; Zietz et al. [@CR295]). However, other studies from Germany show higher levels, with mean concentrations of 4 and 14 ng/g fat (Raab et al. [@CR201]; Schlaud et al. [@CR219]). Two reports investigating dieldrin levels in mothers' milk, both in Denmark and Finland, show similar results (Shen et al. [@CR225], [@CR226]) and likewise from the WHO-UNEP monitoring program (UNEP [@CR263]). The highest levels are reported from the UK with a mean concentration of 48 ng/g fat (Harris et al. [@CR104]) and the Netherlands with a median concentration of 50 ng/g fat (Albers et al. [@CR7]).

### The Americas {#Sec45}

In the Americas, one study has reported levels of aldrin from a known pest-controlled area on the Yucatán peninsula in Mexico with a mean concentration of 280 ng/g fat (Rodas-Ortiz et al. [@CR204]). In the lower end of reported levels of dieldrin in mothers' milk are samples from the Americas, Antigua and Barbuda, Chile, and Uruguay, with mean concentrations of 2.6, 5.0, and 4.9 ng/g fat (UNEP [@CR262]), respectively, as well as from the Group of Latin American and Caribbean countries, with a median concentration of 4.9 ng/g fat (UNEP [@CR263]). The highest levels of dieldrin in mothers' milk in the Americas are found in samples from a know pest-controlled area in on the Yucatán peninsula in Mexico with a mean concentration of 300 ng/g fat (Rodas-Ortiz et al. [@CR204]). Endrin could only be found in a sample from Nicaragua (Romero et al. [@CR206]) and from the abovementioned pest-controlled area on the Yucatán peninsula in Mexico (Rodas-Ortiz et al. [@CR204]).

Pentachlorobenzene, toxaphene, and mirex {#Sec46}
----------------------------------------

Pentachlorobenzene (PCBz), mirex, and toxaphene concentrations in mothers' milk are only reported in a few studies (Table [10](#Tab10){ref-type="table"}). Mirex levels are reported as 16, 20, and 68 ng/g fat in mothers' milk from Germany, Russia, and Canada, respectively (Newsome and Ryan [@CR171]; Polder et al. [@CR195]; Skopp et al. [@CR230]). Both PCBz and mirex are reported in around 1 ng/g fat in most mothers' milk samples, with a few exceptions (Table [10](#Tab10){ref-type="table"}). The most profound exception is mirex found in a concentration of 200 ng/g fat in mothers' milk from Mexico (Rodas-Ortiz et al. [@CR204]).

It is notable that so few reports have been published on these POPs. Therefore, any assessments of spatial differences are impossible.

HBCDD and PBB {#Sec47}
-------------

Concentrations of hexabromocyclododecane (HBCDD) and polybrominated biphenyl (PBB) reported in mothers' milk are presented in Table [11](#Tab11){ref-type="table"} on a fat weight basis. From isomer-specific information, it is clear that α-HBCDD is the most abundant isomer of environmental HBCDDs (Eljarrat et al. [@CR78]; Lankova et al. [@CR144]). The spatial distribution of HBCDD is illustrated in Fig. [9](#Fig9){ref-type="fig"}.Fig. 9Graphical presentation of HBCDD concentrations in mothers' milk from countries worldwide

### Africa {#Sec48}

Only two studies of HBCDDs in mothers' milk from all of Africa were retrieved, both showing subnanogram per gram fat concentrations in the mothers' milk analyzed (Asante et al. [@CR13]; Darnerud et al. [@CR65]). No study was found reporting on PBBs in mothers' milk from any African nation.

### Asia and the Pacific region {#Sec49}

The lowest concentrations of ∑HBCDDs reported in mothers' milk from Asia come from the Philippines and Vietnam with mean and median concentrations below 1 ng/g fat (Malarvannan et al. [@CR159]; Tue et al. [@CR259]). A study from China shows a greater range in ∑HBCDD concentrations, with means of 0.33--2.8 ng/g fat (Shi et al. [@CR227]). In Japanese mothers' milk, ∑HBCDDs levels of 1.4 ng/g fat (Kakimoto et al. [@CR123]) are reported. No study was found reporting on PBBs in mothers' milk from any nation in Asia or the Pacific region.

### Europe {#Sec50}

The levels of ∑HBCDDs in Europe are quite uniform and low (Table [11](#Tab11){ref-type="table"}), i.e., \<1 ng/g fat. However, the highest concentrations on a global scale are those reported from a Spanish study, with a mean concentration of 47 ng/g fat, in mothers' milk from a population living close to a textile processing plant (Eljarrat et al. [@CR78]). The ∑HBCDD concentrations in Swedish samples reported median concentrations within the range of 0.3--0.4 ng/g fat (Glynn et al. [@CR97]). Somewhat higher concentrations, and comparable with the Japanese levels, are reported from Norway, with mean concentrations of 1.7 ng/g fat (Thomsen et al. [@CR252]). The ∑HBCDDs in mothers' milk from the UK report a mean concentration of 6.0 ng/g fat (Abdallah and Harrad [@CR2]), which is the highest background level worldwide, apart from the Spanish "hot spot" samples. One study reports PBB concentrations from two countries, Denmark and Finland, both indicating mean concentrations below 0.3 ng/g fat (Shen et al. [@CR226]).

### The Americas {#Sec51}

We have not found any study with our search criteria which has reported the presence of HBCDDs or PBBs in mothers' milk from any nation in the Americas.

PFOS {#Sec52}
----

Thirteen studies report PFOS concentrations in mothers' milk from a total of 13 countries in Asia and Europe and one study from the USA (Table [12](#Tab12){ref-type="table"}). The concentration of PFOS ranges between 39 and 200 pg/mL, with Hungary as the only exception, 330 pg/mL (Volkel et al. [@CR271]). Due to the limited data, it is not possible to draw any conclusions regarding spatial exposure differences. The spatial distribution of PFOS is illustrated in the diagram in Fig. [10](#Fig10){ref-type="fig"}.Fig. 10Graphical presentation of PFOS concentrations in mothers' milk from countries worldwide

Endosulfan {#Sec53}
----------

Only some scattered endosulfan mothers' milk data are available (Table [13](#Tab13){ref-type="table"}). The sum concentrations from India and Turkey are exceptionally high, i.e., concentrations above 1000 ng/g fat (Cok et al. [@CR55]; Sanghi et al. [@CR210]). These high levels are comparable to some data on DDT in mothers' milk (cf. Table [2](#Tab2){ref-type="table"}) and are likely due to the very recent use of endosulfan in these countries.

Chlordecone {#Sec54}
-----------

No studies were found with our search criteria reporting chlordecone concentrations in mothers' milk.

SCCPs {#Sec55}
-----

No studies were found with our search criteria reporting SCCP concentrations in mothers' milk, even though there is an agency report on SCCPs in Swedish mothers' milk (Darnerud et al. [@CR66]) indicating their presence in this matrix.

Global distribution trends {#Sec56}
--------------------------

The data collected and compiled within the study indicates that there is indeed a difference in the distribution and exposure to POPs which is dependent on where in the world one resides. These conclusions are more easily made when comparing the different spatial distribution diagrams, e.g., Fig. [3](#Fig3){ref-type="fig"}. In general, it was found that DDT/DDE pesticides were reported in higher concentrations in mothers' milk from the regions of Africa, Asia, and Central America, with a propensity for agricultural economies and lower degree of industrialization. On the other hand, PCBs and dioxins were found to be reported to a higher degree in more industrialized regions, such as parts of Asia, Europe, and North America. A good example of this can be seen by comparing Figs. [3](#Fig3){ref-type="fig"} and [4a--c](#Fig4){ref-type="fig"}, where the DDT/DDE concentrations clearly are lower, in general, in Europe and North America compared to the rest of the world (Fig. [3](#Fig3){ref-type="fig"}). Similarly, it can be seen from Fig. [4a--c](#Fig4){ref-type="fig"} that the PCB concentrations are higher in industrialized regions compared to the rest of the world. This pattern is also observed for HCHs, although there are a few observations of high concentrations in mothers' milk samples from Eastern Europe, i.e., Russia, Romania, and Ukraine (Fig. [6a--d](#Fig6){ref-type="fig"}).This pattern is not surprising since PCBs and dioxins, not shown in spatial distribution diagrams, are related to a degree of industrialization, either as chemical products or impurities there within. DDT as well as HCHs has been used as pesticides in SC and has been used in the equatorial and subequatorial regions, which in general are less industrialized and more dependent on agriculture. Furthermore, it is clear that mothers' milk from the USA contains more PBDEs than the rest of the world (Fig. [7](#Fig7){ref-type="fig"}). BDE-47 is a biomarker of PBDE exposure and the lowest reported concentration is around five times as big as the highest concentration in a sample from outside of the USA. This can be explained by the stricter flame retardant policy enforced within the USA, a policy which calls for a greater use of flame retardant substances such as PBDEs primarily in upholstery (GSPI [@CR100]; State of California [@CR233], [@CR234]). A new fire safety regulation has recently been adopted, January 1st 2014, which does not call for the use of flame retardant chemicals and perhaps this will lead to a decrease of PBDEs in mothers' milk in the USA (GSPI [@CR100]; State of California [@CR233], [@CR234]). For the substances not mentioned, there are no observed, clear spatial distribution trends that can be explained by traditional/historical use of the substances in question. This could be since there are too few reported concentrations available or that the differences in use or emissions are too small to observe.

Temporal trends {#Sec57}
===============

Two distinct objectives can be identified concerning temporal trend monitoring of contaminants. One is to quantitatively estimate the rate of changes in contaminant concentration, e.g., as a change in percent per year or as half- or doubling time in number of years. An example of this could be to estimate the response of measures taken to reduce the discharges of various contaminants. Dissimilarities in comparisons between the rate of change in contaminant concentration in mothers' milk and other environmental biological matrices (e.g., fish) can give information about the exposure patterns, i.e., if the mothers are exposed to contaminants not only from local food but also from imported food and the indoor environment, including a variety of man-made technical products. Another objective of temporal trend monitoring is to study emerging new substances and to detect renewed use of banned contaminants. In order to estimate the rate quantitatively with a high statistical power, it is essential to keep the random variation between years as low as possible. Compared to other matrices, mothers' milk seems to show a relatively low random variation (UNEP [@CR261]).

Inclusion of a time series in this review article requires a minimum of five reported data points. Only approximately half of the substance groups from only two countries, Sweden and Japan, fulfilled the described criteria. The temporal trends present data from 1972 to 2011.

In the graphs below, log-linear regression and a smoother test have been carried out. The smoother test checks if the smoother explains significantly more of the variation in concentration, than the regression line (Nicholson et al. [@CR175]).The regression line and/or the smoother are plotted when significant (*α* = 0.05).

DDT and DDT-related compounds {#Sec58}
-----------------------------

In Fig. [11](#Fig11){ref-type="fig"}, the concentrations of DDE (ng/g fat) in the samples from Japan, 1972--1998 (Konishi et al. [@CR134]), and Sweden, 1972--2010 (Athanasiadou and Bergman [@CR15]; Bergman et al. [@CR29]; Lundén and Norén [@CR156]), show significant decreasing trends over the whole time period of −9.1 % (*p* \< 0.001) and −8.5 % (*p* \< 0.001), respectively. The Japanese samples also show significant decreasing concentrations for the last 10 years of −13 % (*p* \< 0.001), while no trend is indicated in the Swedish samples for the last 10 years (estimated during a decade later than for the Japanese samples). The temporal trends for DDT in mothers' milk from Japan and Sweden are of similar magnitude as for DDE. In addition, the trends observed in Swedish mothers' milk for DDE coincide with the trends seen in Swedish freshwater (Nyberg et al. [@CR183]) and marine (Bignert et al. [@CR30]) biota.Fig. 11Temporal trends of DDE (ng/g fat) from Japan (Konishi et al. [@CR134]) and Sweden (Lundén and Norén [@CR156]; Athanasiadou and Bergman [@CR15]; Bergman et al. [@CR29])

The ratio of DDT/DDE (Fig. [12](#Fig12){ref-type="fig"}) shows similar log-linear trends in the samples from Japan, 1972--1998 (Konishi et al. [@CR134]), and Sweden, 1972--2010 (Athanasiadou and Bergman [@CR15]; Bergman et al. [@CR29]; Lundén and Norén [@CR156]). The Japanese samples also show a significant nonlinear trend for the ratio of DDT/DDE, which might indicate that a new release of DDT has occurred during the monitoring period.Fig. 12Temporal trends of the ratio between DDT and DDE (ng/g fat) from Japan (Konishi et al. [@CR134]) and Sweden (Lundén and Norén [@CR156]; Athanasiadou and Bergman [@CR15]; Bergman et al. [@CR29])

PCBs {#Sec59}
----

In Fig. [13](#Fig13){ref-type="fig"}, the concentrations of ∑PCB (ng/g fat) in the samples from Japan, 1972--1998 (Konishi et al. [@CR134]), and Sweden, 1972--2010 (Athanasiadou and Bergman [@CR15]; Bergman et al. [@CR29]; Lundén and Norén [@CR156]), show significant decreasing trends over the whole time period of −7.5 % (*p* \< 0.001) and −6.5 % (*p* \< 0.001), respectively, and for the last 10 years of −7 % (*p* \< 0.001) and −11 % (*p* \< 0.011), respectively. The trends observed in Swedish mothers' milk for ∑PCB coincide with the trends seen in Swedish freshwater (Nyberg et al. [@CR183]) and marine (Bignert et al. [@CR30]) biota.Fig. 13Temporal trends of ΣPCB (ng/g fat) from Japan (Konishi et al. [@CR134]) and Sweden (Lundén and Norén [@CR156]; Athanasiadou and Bergman [@CR15]; Bergman et al. [@CR29])

Only one temporal trend study on congener basis was found for PCBs within this review (from Sweden). In Fig. [14](#Fig14){ref-type="fig"}, the temporal trend for CB-153 (ng/g fat) in the Swedish samples, 1972--2010 (Bergman et al. [@CR29]; Lundén and Norén [@CR156]), is presented. CB-153 shows a significant decreasing trend over the whole time period and for the last 10 years of −4.9 % (*p* \< 0.001) and −5.9 % (*p* \< 0.042), respectively.Fig. 14Temporal trend of CB-153 (ng/g fat) from Sweden (Lundén and Norén [@CR156]; Athanasiadou and Bergman [@CR15]; Bergman et al. [@CR29])

HCB and HCHs {#Sec60}
------------

In Fig. [15](#Fig15){ref-type="fig"}, the concentrations of β-HCH (ng/g fat) in the samples from Japan, 1972--1998 (Konishi et al. [@CR134]), show a significant decreasing trend over the whole time period as well as for the last 10 years of −12 % (*p* \< 0.001) and −11 % (*p* \< 0.001), respectively.Fig. 15Temporal trends of β-HCH (ng/g fat) from Japan (Konishi et al. [@CR134])

PCDDs, PCDFs, and DL-PCBs {#Sec61}
-------------------------

In Fig. [16](#Fig16){ref-type="fig"}, the concentrations of PCDD (pg WHO~2005~-TEQ/g fat) from Stockholm, 1972--1997 (Norén and Meironyte [@CR178]) and 1972--2011 (Fång et al. [@CR84]), show significant decreasing trends over the whole time period of −3.6 % (*p* \< 0.005) and −6.0 % (*p* \< 0.001), respectively. However, for the last 10 years, a significant decreasing trend of −10 % (*p* \< 0.001) is only seen for the time series from 1972 to 2011 (Fång et al. [@CR84]), covering the last decade in contrast to the study from 1972 to 1997 (Norén and Meironyte [@CR178]), which might have too few samples during the last 10 years to detect a trend. It should be noted that the two studies by Norén and Meironyte and the study by Fång et al. are analyzing the same pooled mothers' milk sample during 1972--1997.Fig. 16Two temporal trends of PCDD in WHO~2005~-TEQ (pg/g fat) from Sweden, on the left (Norén and Meironyte [@CR178]) and on the right (Fång et al. [@CR84])

In Fig. [17](#Fig17){ref-type="fig"}, the concentrations of PCDF (pg WHO~2005~-TEQ/g fat) from Stockholm, 1972--1997 (Konishi et al. [@CR134]; Norén and Meironyte [@CR178]) and 1972--2011 (Fång et al. [@CR84]), show significant decreasing trends over the whole time period of −5.2 % (*p* \< 0.003) and −6.2 % (*p* \< 0.001), respectively. However, for the last 10 years, a significant decreasing trend of −7.3 % (*p* \< 0.001) is only seen for the time series from 1972 to 2011 (Fång et al. [@CR84]), covering the last decade in contrast to the study from 1972 to 1997 (Norén and Meironyte [@CR178]), which might have too few samples during the last 10 years (only 4) to detect a trend.Fig. 17Two temporal trends of PCDF in WHO2005-TEQ (pg/g fat) from Sweden, *on the left* (Norén and Meironyte [@CR178]) and *on the right* (Fång et al. [@CR84])

In Fig. [18](#Fig18){ref-type="fig"}, the concentrations of DL-PCBs (pg WHO~2005~-TEQ/g fat) from Stockholm, 1972--1997 (Norén and Meironyte [@CR178]) and 1972--2011 (Fång et al. [@CR84]), show significant decreasing trends over the whole time period of −5.1 % (*p* \< 0.001) and −7.0 % (*p* \< 0.001), respectively. For the last 10 years, a significant decreasing trend of −12 % (*p* \< 0.012) is seen for the samples from 1972 to 2011 (Fång et al. [@CR84]), and a decreasing trend of −6.7 % (*p* \< 0.107) is also indicated in the samples from 1972 to 1997 (Norén and Meironyte [@CR178]).Fig. 18Two temporal trends of dioxin-like PCBs (DL-PCBs) in WHO~2005~-TEQ (pg/g fat) from Sweden, *on the left* (Norén and Meironyte [@CR178]) and *on the right* (Fång et al. [@CR84])

The trends observed in Swedish mothers' milk for DL-PCBs during the whole time period coincide with the trends seen in Swedish freshwater (Nyberg et al. [@CR183]) and marine (Bignert et al. [@CR30]) biota for the dioxin-like PCB congener CB-118 from the end of the 1970s to the beginning of the 1990s. However, during the last decade, the levels are decreasing at a higher rate in Swedish human milk than in marine and freshwater biota from Sweden.

PBDEs {#Sec62}
-----

In Fig. [19](#Fig19){ref-type="fig"}, the concentrations of BDE-47 (ng/g fat) in the samples from Japan, 1977--1999 (Akutsu et al. [@CR4]), indicate an increasing trend over the whole time period of 9.1 % (*p* \< 0.081). In contrast, a decreasing trend of −5.7 % (*p* \< 0.093) is indicated in the Swedish samples from Stockholm (Athanasiadou and Bergman [@CR15]; Bergman et al. [@CR29]; Fängström et al. [@CR85]) for the last 10 years of the study. This decreasing trend of BDE-47 coincides with the trends seen in Swedish marine (Bignert et al. [@CR30]) and freshwater (Nyberg et al. [@CR183]) biota over the last decade. PentaBDE was first phased out voluntarily by the industry in Germany in 1986 and end in Sweden in 1999 (Alcock and Busby [@CR8]). Subsequently, BDE-47 was partially banned within the EU countries in 2004 and the declining concentrations in human milk and biota could to some extent be explained by these events. No trend could be observed in the Swedish time trend from Uppsala during 1996--2001 (Lind et al. [@CR152]).Fig. 19Temporal trends of BDE-47 (ng/g fat) from Japan (Akutsu et al. [@CR4]) and from Stockholm (Athanasiadou and Bergman [@CR15]; Fängström et al. [@CR85]; Bergman et al. [@CR29]) and Uppsala (Lind et al. [@CR152]), Sweden

Heptachlor {#Sec63}
----------

In Fig. [20](#Fig20){ref-type="fig"}, the concentrations of heptachlorepoxide (ng/g fat) in the samples from Japan, 1986--1998 (Konishi et al. [@CR134]), show significant decreasing trends over the whole time period and for the last 10 years of −9.7 % (*p* \< 0.001) and −4.9 % (*p* \< 0.049), respectively.Fig. 20Temporal trend of heptachlorepoxide (ng/g fat) from Japan (Konishi et al. [@CR134])

Dieldrin, endrin, and aldrin {#Sec64}
----------------------------

In Fig. [21](#Fig21){ref-type="fig"}, the concentrations of dieldrin (ng/g fat) in the samples from Japan, 1972--1982 (Konishi et al. [@CR134]), show a significant decreasing trend over the whole time period of −14 % (*p* \< 0.001).Fig. 21Temporal trend of dieldrin (ng/g fat) from Japan (Konishi et al. [@CR134])

HBCDD {#Sec65}
-----

The concentrations in Fig. [22](#Fig22){ref-type="fig"} of HBCDD (ng/g fat) in the samples from Japan, 1987--2007 (Kakimoto et al. [@CR123]) and Sweden, 1987--2010 (Athanasiadou and Bergman [@CR15]; Bergman et al. [@CR29]; Fängström et al. [@CR85]), show increasing trends over the whole time period of 5.4 % per year (*p* \< 0.061) and 7.6 % per year (*p* \< 0.001), respectively. The increasing trend of HBCDD seen in the Swedish milk samples coincides with trends in Swedish marine biota from the Baltic Sea (Bignert et al. [@CR30]). HBCDD is still in use within the EU but is listed in REACHs authorization list as substance of very high concern (SVHC) and, since November 2014, included in the SC.Fig. 22Temporal trends of HBCDD (ng/g fat) from Japan (Kakimoto et al. [@CR123]) and Sweden (Athanasiadou and Bergman [@CR15]; Fängström et al. [@CR85]; Bergman et al. [@CR29])

PFOS {#Sec66}
----

In Fig. [23](#Fig23){ref-type="fig"}, the concentrations of PFOS (pg/ml) in the samples from Stockholm, 1972--2008 (Sundström et al. [@CR245]), show a significant increasing trend over the whole time period of 3.3 % (*p* \< 0.012). In contrast, a significant decreasing trend of −11 % (*p* \< 0.002) is observed for the last 10 years. In the study with samples from Uppsala, Gothenburg, Lund, and Lycksele, 1996--2004 (Kärrman et al. [@CR126]), a decreasing trend is indicated (*p* \< 0.059) for the whole time period. The trends observed in Swedish mothers' milk for PFOS coincide with the trends seen in Swedish marine (Bignert et al. [@CR30]) and freshwater (Nyberg et al. [@CR183]) biota over the last decade.Fig. 23Two temporal trends of PFOS (pg/mL) from Stockholm (Sundström et al. [@CR245]) and Uppsala, Gothenburg, Lund and Lycksele (Kärrman et al. [@CR126]), Sweden

Critical remarks and conclusions {#Sec67}
================================

Some of the legacy POPs are the most well-researched environment pollutants among all. This is due to their global distribution and occurrence in humans and wildlife, being classified as CMRs, having endocrine disruption effects and/or having other toxic effects. Some early efforts focused on the transfer of these chemically stable and bioaccumulative compounds to nursing children. The transfer of POPs via mothers' milk initiated a still ongoing debate on risks for the newborn babies. In contrast to the strict recommendations to nursing mothers to avoid smoking and drinking alcohol, it is not possible to change the mothers' body burdens of POPs as their levels of these compounds have been built up over the mothers' whole lifetime. However, in some countries, there are at least dietary recommendations on how to limit the intake of POPs from some major food sources, in particular fatty fish. These recommendations are primarily targeting young women and women in child-bearing ages. Due to the many positive effects of nursing, WHO recommends mothers to breast feed their newborns for a minimum of 6 months (WHO and UNICEF [@CR282]).

WHO also initiated a monitoring program for POPs in mothers' milk in 1976 (WHO [@CR281]), but at this point, researchers had already started to do exposure studies of nursing infants, as reviewed by Norén and Meironyte ([@CR178]). In the present review, it becomes clear how abundant mothers' milk is a matrix for POP analysis, although only a limited number of POPs are assessed, i.e., 7 of the 24 (HCHs counted individually) POPs in Table [1](#Tab1){ref-type="table"} contribute with 80 % of the exposure studies discussed herein. There are no studies covering all, or even a majority of the POPs in the same study. The most comprehensive results for POP exposure analyses are when the same milk samples are utilized for assessments of as many POPs as possible. In reality, it is much more common with scattered studies globally, regionally and country-wise. This means that the cohorts are defined by different means and the objectives vary. This leads to the conclusion that there are very few studies that allow reliable comparisons, e.g., the temporal trend studies from Japan and Sweden. However, the temporal trend studies from Japan and Sweden presented did not cover POP analyses in an optimal manner, i.e., several of the POPs were not included in these studies. Another issue regarding comprehensive time trend analysis is the need to establish environmental specimen banks whose goal is to collect and store environmental relevant samples, including mothers' milk, in a structured manner. In time, samples collected will allow a high qualitative time trend analysis on current POPs and currently unknown pollutants. Further, this is only the start of the problem comparing POPs in mothers' milk from around the world. Below, we list and shortly discuss some of the major shortcomings in some studies which, if rectified, would allow proper comparisons of POPs in mothers' milk.

Reporting base for POP concentrations in mothers' milk {#FPar1}
------------------------------------------------------

This is relevant for all POPs that are produced, used, and/or occur as mixtures of halogenated homologues and isomers-congeners. These POPs are PCBs, PCDFs, PCDDs, PBDEs, PBBs, chlordanes, toxaphen, and CPs. HCHs may be included even though only isomers of hexachlorinated cyclohexane is included. Similarly, HBCDD has three diastereomers (α-, β-, and γ-HBCDD), which are commonly discussed and often reported individually. DDTs and endosulfan, on the other hand, are both produced as two main isomers. However, both 4,4′-DDT and 2,4′-DDT are transformed to and occur in the environment, including mothers' milk, as the corresponding DDD and DDE compounds. This has led to a similar handling of the DDTs as of true congeners of, e.g., PCBs. For all of these compounds/compound classes, it is common to report concentration sums (e.g., sPCB or ∑PCB), sometimes indicating how many PCB congeners are included in the sum and presented as ∑PCB(7), indicating that seven congeners were included. However, highly variable sums are reported for the POPs. For PCBs, for example, a number of different sum values have been found in the review including 3, 4, 6, 7, 8, 12, 15, 16, 19, 32, and 35 PCB congeners. Sometimes, the reported sum concentrations are referred to as "total PCBs" without any further specification. However, it is clear that it is still a summation of a defined number of PCB congeners, i.e., those quantified. To further complicate the issue, PCBs can also be reported as DL-PCBs and non-DL-PCBs or as non-*ortho*-PCBs, mono-*ortho*-PCBs, and di-*ortho*-PCBs. Hence, it is realistically not possible to compare ∑PCB concentrations unless they are reported in a similar manner. In this review article, we have used ∑PCB data but these are the weakest, the most unreliable, while the ∑PCB(6) and CB-153 concentration data are comparable if reported similarly by other means (mean, median, fat or fresh weight basis, cf. below).

The concentration reports for PBDEs follow a similar pattern as for the PCBs, often reporting ∑PBDEs but with differences in number and identity of PBDE congeners. Still, we have chosen to show ∑PBDE levels in Table [7](#Tab7){ref-type="table"}, but for the purpose of comparison, BDE-47 and BDE-209 are recommended for use. The reporting variability applies for all POPs that have isomers and congeners and for which individual reference standards for analysis are available. The latter allows congener-, or isomer-, specific analysis, but the complexity of data generated call for simplifications.

Two classes of POPs, DDTs and dioxins, require further attention regarding concentration reports. The DDTs are commonly reported as the sum of 4,4′-DDT and its metabolites, 4,4′-DDE (major transformation product) and 4,4′-DDD. However, the ∑DDT may also include the true isomers, 2,4′-DDT and 4,4′-DDT or even the two isomers plus their metabolites. Concentrations of the abundant compounds 4,4′-DDT, 4,4′-DDE, and 4,4′-DDD are however quite frequently reported. This allows proper comparisons of the concentrations and to calculate comparable ratios of DDT versus either DDE or DDE and DDD, which can be done using different methods. In Table [2](#Tab2){ref-type="table"}, we have applied the ratio 4,4′-DDT/4,4′-DDE due to the abundance of individual concentration data for these two pollutants.

The reporting of dioxin concentrations is another problem, even though individual concentration data are generated from the chemical analyses. The actual concentrations of dioxins (PCDDs, PCDFs, and DL-PCBs) are commonly reported as sum of their TEQs, after recalculation of the concentrations utilizing the TEF values---the most commonly used nowadays are the WHO TEFs from 1998 and 2005 (Van den Berg et al. [@CR266], [@CR267]). However, if the ∑PCDDs, ∑PCDFs, and ∑DL-PCBs, or worse ∑dioxins, are presented, it is strongly limiting any comparisons, unless the actual concentration data of the individual congeners are presented as well.

In conclusion, POPs in mothers' milk, as well as in other matrices, must be reported on a congener- or isomer-specific basis to promote proper trend studies. Unfortunately, this is not done in a structured manner today, which is strongly hampering the comparisons in the present data set on POPs in mothers' milk.

Concentration base for POPs in mothers' milk {#FPar2}
--------------------------------------------

The most common way of reporting concentrations of POPs in human matrices and wildlife is on weight basis, i.e., microgram, nanogram, picogram per weight of the matrix (gram or kilogram), or on volume (e.g., mL) of the matrix, which relates to a fresh weight, volume, or extracted lipids/fats. The concentrations are rarely reported on a molar base (e.g., nmol/g or pmol/g). Despite the fact that this is the correct way of assessing exposures used for risk assessments and for correct comparisons, this means reporting is only found in very few studies of POPs in mothers' milk. This problem is particularly evident for the polybrominated pollutants, where the molecular weight varies greatly between the different congeners. The implications are shown in Fig. [24](#Fig24){ref-type="fig"}, where it is clear that the "number of molecules" (molar base) of CB-153 is 2.5 times the number of BDE-209, although the masses of the two are equal. Since there is such an extensive span in molecular masses among the POPs, it is crucial that this must be considered for future studies/reports on POPs.Fig. 24Comparison between CB-153 and BDE-209 on a weight (ng/g) and molar (pmol/g) basis

Another obstacle for comparisons of POPs in mothers' milk is how to handle more water-soluble POPs, e.g., PFOS, other perfluorinated compounds, and organohalogen phenols. PFOS is commonly reported on a fresh weight basis, i.e., picograms per milliliter, while other POPs are reported on a fat weight basis (e.g., ng/g fat). To allow conversions, it is necessary to know the fat content of the matrix analyzed.

In conclusion, a change from weight- to molar-based reporting on POPs is needed in order to avoid unnecessary errors in exposure assessments and to allow accurate trend analyses. Furthermore, the fresh weight of mothers' milk samples as well as concentrations on fat weight basis, and vice versa, should be mandatory since this would facilitate comparisons between studies.

Reporting {#FPar3}
---------

The reported measure of central tendency of the concentrations of POPs is not consistent, i.e., the arithmetic mean, the geometric mean, or median values, and sometimes, only a range is given without a mean or a median. This hampers the possibilities to compare data. However, if a log-normal distribution can be assumed, which is common for contaminant data (see, e.g., Esmen and Hammad [@CR83]), the geometric mean and the median can be considered equal. The arithmetic mean is, with the same assumption of log-normality, always higher than the median. Some guidance of how to adjust for this bias is given by Caudill ([@CR37], [@CR38]). In conclusion, commonly agreed upon guidelines for this part in reporting exposure data are also required.

Overall conclusions {#FPar4}
-------------------

Unfortunately, reporting of POPs in mothers' milk differs greatly between the studies. This has limited the comparisons for both spatial and temporal trend studies.
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